caffeine and Obesity
caffeine has been researched along with Obesity in 240 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "This systematic review aimed to study caffeine's effect on the cardiometabolic markers of the metabolic syndrome and to evaluate caffeine's application as a potential therapeutic agent in rat models." | 9.41 | Systematic review of the effect of caffeine therapy effect on cardiometabolic markers in rat models of the metabolic syndrome. ( Al Ansari, AM; Alabbasi, AMA; Alhadi, IA; AlSaleh, AFF, 2023) |
| "We investigated whether obesity adversities such as excessive body fat, compensatory hyperinsulinemia, metabolic endotoxemia, irregular androgenicity, and reduced cardiorespiratory and anaerobic fitness are ameliorated by high-intensity interval training (HIIT) with or without caffeine supplementation in women with obesity." | 9.34 | Caffeine Optimizes HIIT Benefits on Obesity-associated Metabolic Adversity in Women. ( Alkhatib, A; Hou, CW; Hsieh, MJ; Kuo, CH, 2020) |
| "We have previously shown that a combination of glucosyl hesperidin (G-hesperidin) plus caffeine reduces accumulation of body fat, whereas G-hesperidin or caffeine alone shows little effect on high-fat diet-induced obesity in mice." | 9.22 | Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial. ( Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y, 2016) |
| "To evaluate the effects of combination caffeine/ephedrine and leptin A-200 on visceral fat mass and weight loss over 24 weeks." | 9.17 | The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. ( Fujioka, K; Greenway, FL; Liu, AG; Smith, SR, 2013) |
| "Caffeine ingestion decreases the insulin sensitivity index (ISI) for an oral-glucose-tolerance test (OGTT) and decreases insulin-induced glucose disposal in lean male subjects during a hyperinsulinemic clamp." | 9.11 | Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. ( Belfie, LM; Chown, SE; Conquer, JA; Duncan, AM; Graham, TE; McLaren, DH; Petrie, HJ, 2004) |
| "Investigation of the effect of a green tea-caffeine mixture on weight maintenance after body weight loss in moderately obese subjects in relation to habitual caffeine intake." | 9.11 | Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. ( Kovacs, EM; Lejeune, MP; Westerterp-Plantenga, MS, 2005) |
| "To compare caffeine pharmacokinetics (200 mg single oral dose) between obese and lean subjects and in obese subjects prior to and following weight reduction." | 9.08 | Caffeine pharmacokinetics in obesity and following significant weight reduction. ( Berry, EM; Caraco, Y; Levy, M; Zylber-Katz, E, 1995) |
| "In previous separate studies, dexfenfluramine (DF) and ephedrine/caffeine (EC) have been shown to promote weight loss in obese patients as compared with placebo." | 9.07 | Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. ( Ahlstrøm, F; Breum, L; Frimodt-Møller, J; Pedersen, JK, 1994) |
| "The effects of obesity, exercise, and the interaction of obesity and exercise were examined in 6 caffeine naive, untrained, nonsmoking, college males (3 lean (LV), 3 obese (OV]." | 9.06 | The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers. ( Kamimori, GH; Knowlton, RG; Perkins, RM; Somani, SM, 1987) |
| "Since passage of the Dietary Supplement Health and Education Act of 1994, the sale of herbal dietary supplements containing caffeine and ephedrine for weight loss has become widespread in the United States." | 8.81 | The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. ( Greenway, FL, 2001) |
| "High intakes of dietary caffeine was associated with lower LDL, SBP, insulin resistance and higher HDL concentrations among overweight and obese individuals." | 8.31 | Dietary caffeine intake is associated with favorable metabolic profile among apparently healthy overweight and obese individuals. ( Abid, MK; Almalki, SG; Alshahrani, SH; Atia, YA; Badir, RA; Hussien, BM; Ramaiah, P; Romero-Parra, RM; Shahab, S; Tayyib, NA, 2023) |
| "In observational studies, caffeine has been associated with a lower risk of obesity." | 8.12 | Associations of Blood Caffeine and Genetically Predicted Coffee Consumption with Anthropometric Measures of Obesity: A Two Sample Mendelian Randomization Study. ( Narayan, VP; Yoon, SY, 2022) |
| "Greater caffeine consumption in pregnancy is associated with reduced birth size, but potential associations with childhood growth are unclear." | 8.12 | Association of Maternal Caffeine Consumption During Pregnancy With Child Growth. ( Gilman, SE; Gleason, JL; Grantz, KL; Grobman, WA; Hinkle, SN; Hunt, KJ; Kannan, K; Mitro, SD; Nageotte, M; Newman, RB; Robinson, M; Skupski, DW; Sundaram, R; Zhang, C, 2022) |
| "Epigallocatechin-3-gallate (EGCG) and caffeine in tea exert anti-obesity effects and induces nonalcoholic fatty liver disease (NAFLD) amelioration." | 7.91 | Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats. ( An, HM; Huang, JA; Lin, HY; Liu, ZH; Ou, XC; Wen, BB; Xiong, YF; Yang, Z; Zhang, YB; Zhu, MZ, 2019) |
| "Maternal antenatal, but not paternal or grandparental, caffeine intake is associated with higher offspring adiposity and obesity risk at age 5 and 9 y, with stronger associations observed for coffee caffeine." | 7.91 | Maternal, but not paternal or grandparental, caffeine intake is associated with childhood obesity and adiposity: The Lifeways Cross-Generation Cohort Study. ( Chen, LW; Kelleher, CC; Mehegan, J; Murrin, CM; Phillips, CM, 2019) |
| "To develop an anti-obesity agent, we examined the combination effect of glucosyl hesperidin (G-hesperidin) and caffeine on obesity in mice." | 7.81 | A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice. ( Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y, 2015) |
| "Beneficial effects of green tea (Camellia sinensis, Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major components of green tea, polysaccharides, polyphenols and caffeine is not clear." | 7.81 | The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet. ( Dai, S; Wu, T; Xu, J; Xu, Y; Zhang, M; Zhou, Z, 2015) |
| "Caffeine is consumed by more than 85% of adults and little is known about its role on erectile dysfunction (ED) in population-based studies." | 7.80 | Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004. ( Canfield, S; Daniel, CR; Lopez, DS; Sinha, A; Tsilidis, KK; Wang, R; Zhu, H, 2014) |
| "The antiobesity effects of Chinese black tea (Pu-erh tea) and of gallic acid (GA) were investigated using in vitro and in vivo assays." | 7.78 | Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid. ( Fujita, H; Hou, IC; Oi, Y; Yazawa, K, 2012) |
| " Decreased TST and increased caffeine intake and screen time may result in higher obesity risk in the adolescent population." | 7.77 | Caffeine and screen time in adolescence: associations with short sleep and obesity. ( Drescher, AA; Goodwin, JL; Quan, SF; Silva, GE, 2011) |
| "To investigate the hypothesis that the peripheral actions of caffeine and ephedrine to increase sympathetic tone and metabolic rate and to preserve lean tissue will cause weight loss in patients with hypothalamic obesity." | 7.74 | Treatment of hypothalamic obesity with caffeine and ephedrine. ( Bray, GA; Greenway, FL, 2008) |
| "Caffeine consumption is associated with a substantial reduction in insulin-mediated glucose uptake independent of obesity, type 2 diabetes, and chronic exercise." | 7.73 | Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. ( Graham, TE; Hudson, R; Kilpatrick, K; Lee, S; Ross, R, 2005) |
| "To clarify whether there were any differences in basal metabolic rate (BMR) and thermogenic response to caffeine in individual obese women, and if so, whether such differences affected weight loss, the basal and resting metabolic rates at 30 min after a caffeine loading test (4 mg/kg ideal body weight, per os) were measured in 136 obese women and ten lean age-matched controls." | 7.69 | Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. ( Kondo, M; Sakane, N; Umekawa, T; Yoshida, T, 1994) |
| "Administration of a thermogenic mixture of ephedrine, caffeine and theophylline to grossly obese (11-12 mo old) fa/fa Zucker rats led to a rapid decline in their body weight, which reached lean levels within 9-10 wk, and this postobese weight was maintained for another 5-6 wk." | 7.67 | Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture. ( Dulloo, AG; Miller, DS, 1987) |
| "Obesity is considered one of the most crucial health problems of the century." | 5.91 | Anti-obesity effects of chlorogenic acid and caffeine- lipid nanoparticles through PPAR-γ/C/EBP-ɑ pathways. ( Macit Celebi, MS; Uner, B, 2023) |
| "Obesity was induced in mice by high-fat diet and the tested compounds (KD-64 and caffeine) were administrated for 21 days." | 5.56 | KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice. ( Bednarski, M; Drabczyńska, A; Dziubina, A; Kieć-Kononowicz, K; Kotańska, M; Mika, K; Reguła, K; Sapa, J; Szafarz, M; Zygmunt, M, 2020) |
| "This systematic review aimed to study caffeine's effect on the cardiometabolic markers of the metabolic syndrome and to evaluate caffeine's application as a potential therapeutic agent in rat models." | 5.41 | Systematic review of the effect of caffeine therapy effect on cardiometabolic markers in rat models of the metabolic syndrome. ( Al Ansari, AM; Alabbasi, AMA; Alhadi, IA; AlSaleh, AFF, 2023) |
| "The treatment with caffeine in the rats fed the high-carbohydrate, high-fat diet decreased body fat and systolic blood pressure, improved glucose tolerance and insulin sensitivity, and attenuated cardiovascular and hepatic abnormalities, although the plasma lipid concentrations were further increased." | 5.38 | Caffeine attenuates metabolic syndrome in diet-induced obese rats. ( Brown, L; Kauter, K; Panchal, SK; Ward, LC; Wong, WY, 2012) |
| "Ephedrine is a sympathicomimetic agent that stimulates the central nervous and cardiovascular systems and causes bronchodilatation." | 5.31 | [Ephedrine and ephedra in weight loss products and other preparations]. ( Stricker, BH; van der Hooft, CS, 2002) |
| " Since clearance of caffeine is not related to body weight, these data indicate that a chronic dosing regimen to maintain a given plasma caffeine concentration should not be altered due to obesity." | 5.27 | Caffeine disposition in obesity. ( Abernethy, DR; Schwartz, JB; Todd, EL, 1985) |
| "Green tea consumption has been associated with favorable changes in body weight and obesity-related hormones, although it is not known whether these changes result from green tea polyphenols or caffeine." | 5.22 | Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women. ( Arikawa, AY; Dostal, AM; Espejo, L; Kurzer, MS; Samavat, H; Stendell-Hollis, NR, 2016) |
| "We have previously shown that a combination of glucosyl hesperidin (G-hesperidin) plus caffeine reduces accumulation of body fat, whereas G-hesperidin or caffeine alone shows little effect on high-fat diet-induced obesity in mice." | 5.22 | Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial. ( Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y, 2016) |
| "Thirty-three volunteers (16 normal-weight, 17 overweight/obese) participated in three trials: they consumed a standard breakfast along with 200 ml of either coffee with 3 or 6 mg caffeine/kg body weight (Coffee 3 and Coffee 6, respectively), or water." | 5.17 | Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals. ( Fragopoulou, E; Gavrieli, A; Kardatou, E; Karfopoulou, E; Mantzoros, CS; Spyreli, E; Yannakoulia, M, 2013) |
| "To evaluate the effects of combination caffeine/ephedrine and leptin A-200 on visceral fat mass and weight loss over 24 weeks." | 5.17 | The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss. ( Fujioka, K; Greenway, FL; Liu, AG; Smith, SR, 2013) |
| "These data suggest the extra energy in SSBs as a result of caffeine's effect on sweetness may be associated with adult and child weight gain." | 5.15 | The influence of caffeine on energy content of sugar-sweetened beverages: 'the caffeine-calorie effect'. ( Keast, RS; Riddell, LJ; Sacks, G; Sayompark, D; Swinburn, BA, 2011) |
| "Dairy calcium supplementation in overweight subjects with habitually low calcium intakes failed to alter fat metabolism and energy expenditure under resting conditions and during acute stimulation by caffeine or epinephrine." | 5.13 | Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism. ( Acheson, KJ; Bortolotti, M; Loizon, E; Rudelle, S; Schneiter, P; Tappy, L; Vidal, H, 2008) |
| "Caffeine ingestion decreases the insulin sensitivity index (ISI) for an oral-glucose-tolerance test (OGTT) and decreases insulin-induced glucose disposal in lean male subjects during a hyperinsulinemic clamp." | 5.11 | Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. ( Belfie, LM; Chown, SE; Conquer, JA; Duncan, AM; Graham, TE; McLaren, DH; Petrie, HJ, 2004) |
| "To evaluate the effect of a dietary supplement containing herbal caffeine (70 mg/dose) and ephedra (24 mg/dose; C&E) on metabolic rate, weight loss, body composition, and safety parameters." | 5.11 | Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. ( Blanchard, D; De Jonge, L; Frisard, M; Greenway, FL; Smith, SR, 2004) |
| "Caffeine ingestion negatively affects insulin sensitivity during an oral glucose tolerance test (OGTT) in lean and obese men, but this has not been studied in individuals with type 2 diabetes." | 5.11 | Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. ( Battram, DS; Graham, TE; McLaren, DH; Robinson, LE; Sathasivam, P; Savani, S, 2004) |
| "Investigation of the effect of a green tea-caffeine mixture on weight maintenance after body weight loss in moderately obese subjects in relation to habitual caffeine intake." | 5.11 | Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. ( Kovacs, EM; Lejeune, MP; Westerterp-Plantenga, MS, 2005) |
| "To compare caffeine pharmacokinetics (200 mg single oral dose) between obese and lean subjects and in obese subjects prior to and following weight reduction." | 5.08 | Caffeine pharmacokinetics in obesity and following significant weight reduction. ( Berry, EM; Caraco, Y; Levy, M; Zylber-Katz, E, 1995) |
| "In previous separate studies, dexfenfluramine (DF) and ephedrine/caffeine (EC) have been shown to promote weight loss in obese patients as compared with placebo." | 5.07 | Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice. ( Ahlstrøm, F; Breum, L; Frimodt-Møller, J; Pedersen, JK, 1994) |
| "The sympathomimetic agent ephedrine has potent thermogenic and anti-obesity properties in rodents." | 5.07 | The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. ( Astrup, A; Breum, L; Hein, P; Quaade, F; Toubro, S, 1992) |
| "The thermogenic effect of an over-the-counter preparation containing 22 mg ephedrine, 30 mg caffeine and 50 mg theophylline was investigated in human volunteers with a predisposition to obesity and also in the lean." | 5.06 | The thermogenic properties of ephedrine/methylxanthine mixtures: human studies. ( Dulloo, AG; Miller, DS, 1986) |
| "The effects of obesity, exercise, and the interaction of obesity and exercise were examined in 6 caffeine naive, untrained, nonsmoking, college males (3 lean (LV), 3 obese (OV]." | 5.06 | The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers. ( Kamimori, GH; Knowlton, RG; Perkins, RM; Somani, SM, 1987) |
| " Caffeine has been found to influence the energy balance by increasing EE and decreasing EI, therefore, it can potentially be useful as a body weight regulator." | 4.95 | The effect of caffeine on energy balance. ( Harpaz, E; Tamir, S; Weinstein, A; Weinstein, Y, 2017) |
| " This report reviews the current literature on sleep patterns in adolescents, factors contributing to chronic sleep loss (ie, electronic media use, caffeine consumption), and health-related consequences, such as depression, increased obesity risk, and higher rates of drowsy driving accidents." | 4.90 | Insufficient sleep in adolescents and young adults: an update on causes and consequences. ( Owens, J, 2014) |
| " However, caffeine at high doses can increase anxiety, insomnia, calcium loss and possibly the risk of fractures." | 4.89 | Coffee and tea: perks for health and longevity? ( Bhatti, SK; Lavie, CJ; O'Keefe, JH, 2013) |
| " Tools for obesity management, including consumption of caffeine, capsaicin and different teas such as green, white and oolong tea, have been proposed as strategies for weight loss and weight maintenance, as they may increase energy expenditure (4-5%), fat oxidation (10-16%) and have been proposed to counteract the decrease in metabolic rate that is present during weight loss." | 4.86 | Thermogenic ingredients and body weight regulation. ( Hursel, R; Westerterp-Plantenga, MS, 2010) |
| "Potentially remediable risk factors include frequency of migraine attacks, obesity, excessive use of medications containing opioids and barbiturates, caffeine overuse, stressful life events, depression, sleep disorders and cutaneous allodynia." | 4.85 | What predicts the change from episodic to chronic migraine? ( Bigal, ME; Lipton, RB, 2009) |
| "Different outcomes of the effect of green tea on weight loss (WL) and weight maintenance (WM) have been reported in studies with subjects differing in ethnicity and habitual caffeine intake." | 4.85 | The effects of green tea on weight loss and weight maintenance: a meta-analysis. ( Hursel, R; Viechtbauer, W; Westerterp-Plantenga, MS, 2009) |
| "Research has shown that advancing age, a history of a sexually transmitted infection and/or pelvic inflammatory disease, extremes of body weight, and tobacco and caffeine use are potentially modifiable risk factors in the development of impaired fertility." | 4.83 | Modifiable risk factors for impaired fertility in women: what nurse practitioners need to know. ( Kelly-Weeder, S; O'Connor, A, 2006) |
| "Since passage of the Dietary Supplement Health and Education Act of 1994, the sale of herbal dietary supplements containing caffeine and ephedrine for weight loss has become widespread in the United States." | 4.81 | The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. ( Greenway, FL, 2001) |
| "Thermogenic combinations of ephedrine with caffeine and newer selective beta 3-agonists are being assessed for the treatment of obesity." | 4.78 | Pharmacology of thermogenic drugs. ( Astrup, A; Christensen, NJ; Quaade, F; Toubro, S, 1992) |
| " To seek RNAs involved in the anxiety disorder-metabolic disorder link, we subjected zebrafish larvae to caffeine-induced anxiety or high-fat diet (HFD)-induced obesity followed by RNA sequencing and analyses." | 4.31 | Inversely Regulated Inflammation-Related Processes Mediate Anxiety-Obesity Links in Zebrafish Larvae and Adults. ( Goldberg, D; Madrer, N; Meerson, A; Soreq, H; Yehuda, H, 2023) |
| "High intakes of dietary caffeine was associated with lower LDL, SBP, insulin resistance and higher HDL concentrations among overweight and obese individuals." | 4.31 | Dietary caffeine intake is associated with favorable metabolic profile among apparently healthy overweight and obese individuals. ( Abid, MK; Almalki, SG; Alshahrani, SH; Atia, YA; Badir, RA; Hussien, BM; Ramaiah, P; Romero-Parra, RM; Shahab, S; Tayyib, NA, 2023) |
| "Greater caffeine consumption in pregnancy is associated with reduced birth size, but potential associations with childhood growth are unclear." | 4.12 | Association of Maternal Caffeine Consumption During Pregnancy With Child Growth. ( Gilman, SE; Gleason, JL; Grantz, KL; Grobman, WA; Hinkle, SN; Hunt, KJ; Kannan, K; Mitro, SD; Nageotte, M; Newman, RB; Robinson, M; Skupski, DW; Sundaram, R; Zhang, C, 2022) |
| "Caffeine has an anti-obesity effect, although chronic excessive caffeine consumption also causes caffeinism, which is marked by increased anxiety or depression, amongst other symptoms." | 4.02 | Astilbin lowers the effective caffeine dose for decreasing lipid accumulation via activating AMPK in high-fat diet-induced obese mice. ( Yang, L; Zheng, G; Zhong, S; Zhu, Y, 2021) |
| " The combination of CGA and caffeine effectively decreased body weight gain, intraperitoneal adipose tissue weight, serum LDL-c, FFA, TC, TG, leptin, IL-6 concentrations, and hepatic TG and TC levels and increased the serum adiponectin level." | 3.91 | Collaborative effects of chlorogenic acid and caffeine on lipid metabolism via the AMPKα-LXRα/SREBP-1c pathway in high-fat diet-induced obese mice. ( Chu, L; Li, X; Liao, M; Lin, L; Xu, M; Yang, L; Zheng, G; Zhu, Y, 2019) |
| "Epigallocatechin-3-gallate (EGCG) and caffeine in tea exert anti-obesity effects and induces nonalcoholic fatty liver disease (NAFLD) amelioration." | 3.91 | Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats. ( An, HM; Huang, JA; Lin, HY; Liu, ZH; Ou, XC; Wen, BB; Xiong, YF; Yang, Z; Zhang, YB; Zhu, MZ, 2019) |
| "Maternal antenatal, but not paternal or grandparental, caffeine intake is associated with higher offspring adiposity and obesity risk at age 5 and 9 y, with stronger associations observed for coffee caffeine." | 3.91 | Maternal, but not paternal or grandparental, caffeine intake is associated with childhood obesity and adiposity: The Lifeways Cross-Generation Cohort Study. ( Chen, LW; Kelleher, CC; Mehegan, J; Murrin, CM; Phillips, CM, 2019) |
| " Caffeine has anti-inflammation, antihepatic steatosis, and anti-insulin resistance effects." | 3.88 | Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats. ( Hou, MC; Hsieh, YC; Huang, CC; Huang, SF; Lee, FY; Lee, KC; Lee, SD; Li, TH; Lin, HC; Lin, MW; Liu, CW; Su, YB; Tsai, CY; Tsai, HC; Yang, YY, 2018) |
| "The anti-obesity effects of resveratrol shown in rodents are not transposed into an efficient therapy of human obesity." | 3.85 | Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes. ( Belles, C; Briot, A; Carpéné, C; Fernández-Quintela, A; Gomez-Zorita, S; Portillo, MP, 2017) |
| "To develop an anti-obesity agent, we examined the combination effect of glucosyl hesperidin (G-hesperidin) and caffeine on obesity in mice." | 3.81 | A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice. ( Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y, 2015) |
| "Beneficial effects of green tea (Camellia sinensis, Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major components of green tea, polysaccharides, polyphenols and caffeine is not clear." | 3.81 | The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet. ( Dai, S; Wu, T; Xu, J; Xu, Y; Zhang, M; Zhou, Z, 2015) |
| "This study does not support an increased risk of childhood obesity with increasing maternal caffeine consumption during pregnancy." | 3.81 | Maternal serum paraxanthine during pregnancy and offspring body mass index at ages 4 and 7 years. ( Keim, SA; Klebanoff, MA, 2015) |
| " Despite a more favorable body composition, rats displayed profound systemic insulin resistance, likely due to caffeine." | 3.80 | Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics. ( Ardell, KL; Bomhof, MR; Cowan, TE; Palmnäs, MS; Reimer, RA; Shearer, J; Vogel, HJ; Yang, J, 2014) |
| "Caffeine is consumed by more than 85% of adults and little is known about its role on erectile dysfunction (ED) in population-based studies." | 3.80 | Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004. ( Canfield, S; Daniel, CR; Lopez, DS; Sinha, A; Tsilidis, KK; Wang, R; Zhu, H, 2014) |
| "The antiobesity effects of Chinese black tea (Pu-erh tea) and of gallic acid (GA) were investigated using in vitro and in vivo assays." | 3.78 | Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid. ( Fujita, H; Hou, IC; Oi, Y; Yazawa, K, 2012) |
| " Decreased TST and increased caffeine intake and screen time may result in higher obesity risk in the adolescent population." | 3.77 | Caffeine and screen time in adolescence: associations with short sleep and obesity. ( Drescher, AA; Goodwin, JL; Quan, SF; Silva, GE, 2011) |
| "To investigate the hypothesis that the peripheral actions of caffeine and ephedrine to increase sympathetic tone and metabolic rate and to preserve lean tissue will cause weight loss in patients with hypothalamic obesity." | 3.74 | Treatment of hypothalamic obesity with caffeine and ephedrine. ( Bray, GA; Greenway, FL, 2008) |
| "Caffeine consumption is associated with a substantial reduction in insulin-mediated glucose uptake independent of obesity, type 2 diabetes, and chronic exercise." | 3.73 | Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. ( Graham, TE; Hudson, R; Kilpatrick, K; Lee, S; Ross, R, 2005) |
| "Increases in caffeine intake may lead to a small reduction in long-term weight gain." | 3.73 | Changes in caffeine intake and long-term weight change in men and women. ( Hu, FB; Lopez-Garcia, E; Manson, JE; Rajpathak, S; van Dam, RM; Willett, WC, 2006) |
| "Higher intake of iron, sugar, and caffeine, in addition to obesity, account largely for higher fibrinogen levels with Westernized lifestyle." | 3.73 | Dietary factors related to higher plasma fibrinogen levels of Japanese-americans in hawaii compared with Japanese in Japan. ( Curb, JD; Miura, K; Nakagawa, H; Okayama, A; Okuda, N; Rodriguez, BL; Saitoh, S; Sakata, K; Stamler, J; Ueshima, H; Yoshita, K, 2006) |
| "To describe the baseline healthy lifestyle behaviors (dietary, calcium, vitamin D, caffeine and alcohol intake, smoking history, and physical activity) of postmenopausal breast cancer survivors (BCS); and to identify any relationship of healthy lifestyle behaviors with bone mineral density (BMD) at the forearm, total hip and spine, L1-L4." | 3.73 | Health behaviors in breast cancer survivors experiencing bone loss. ( Gross, GJ; Lindsey, AM; Ott, CD; Twiss, JJ; Waltman, NL, 2006) |
| "In Western society, the triad of hypertension, metabolic syndrome and obesity (which caries a high risk for renal disease) is increasing, as is the intake of caffeine." | 3.71 | Renal and metabolic effects of caffeine in obese (fa/fa(cp)), diabetic, hypertensive ZSF1 rats. ( Bastacky, SI; Jackson, EK; Kusaka, H; Tofovic, SP, 2001) |
| "The administration of ephedrine and caffeine (E+C) has been proposed to promote weight loss by increasing energy expenditure and decreasing food intake." | 3.70 | Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. ( Colman, RJ; Kemnitz, JW; Ramsey, JJ; Swick, AG, 1998) |
| "It was demonstrated that the anti-obesity effects of oolong tea in high-fat diet-treated mice might be due partly to the enhancing effect of caffeine isolated from oolong tea on noradrenaline-induced lipolysis in adipose tissue, and to the inhibitory action of some other substance in oolong tea on pancreatic lipase activity." | 3.70 | Anti-obesity action of oolong tea. ( Han, LK; Kimura, Y; Li, J; Okuda, H; Takaku, T, 1999) |
| "At variance with what is observed in adulthood obesity, prepubertal obese subjects show an intact adrenomedullary response to caffeine." | 3.70 | Adrenomedullary response to caffeine in prepubertal and pubertal obese subjects. ( Biella, O; Bondi, M; Grugni, G; Menozzi, R; Morabito, F; Rio, GD; Velardo, A; Venneri, MG, 1999) |
| "To evaluate, in compliant patients, the pharmaceutical costs of treating obesity with fenfluramine/mazindol, fenfluramine/phentermine, caffeine/ephedrine, or mazindol relative to the pharmaceutical costs of treating obesity-related comorbid conditions and reducing cardiovascular risk." | 3.70 | Pharmaceutical cost savings of treating obesity with weight loss medications. ( Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW, 1999) |
| "To clarify whether there were any differences in basal metabolic rate (BMR) and thermogenic response to caffeine in individual obese women, and if so, whether such differences affected weight loss, the basal and resting metabolic rates at 30 min after a caffeine loading test (4 mg/kg ideal body weight, per os) were measured in 136 obese women and ten lean age-matched controls." | 3.69 | Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women. ( Kondo, M; Sakane, N; Umekawa, T; Yoshida, T, 1994) |
| "Administration of a thermogenic mixture of ephedrine, caffeine and theophylline to grossly obese (11-12 mo old) fa/fa Zucker rats led to a rapid decline in their body weight, which reached lean levels within 9-10 wk, and this postobese weight was maintained for another 5-6 wk." | 3.67 | Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture. ( Dulloo, AG; Miller, DS, 1987) |
| "An over-the-counter preparation containing ephedrine, caffeine, and theophylline was examined for thermogenic anti-obesity properties." | 3.67 | The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies. ( Dulloo, AG; Miller, DS, 1986) |
| " The metabolic response of lean and obese women to caffeine was studied to see if caffeine could be used to demonstrate the subnormal thermogenesis in obesity previously shown after standard meals or intravenous infusions of noradrenaline." | 3.66 | Caffeine: its effect on catecholamines and metabolism in lean and obese humans. ( Barrand, MA; Callingham, BA; James, WP; Jung, RT; Shetty, PS, 1981) |
| "Obesity has become one of the major public health problems in both the developing and developed countries." | 3.01 | Role of purinergic signalling in obesity-associated end-organ damage: focus on the effects of natural plant extracts. ( Che, H; Deng, Y; Huang, Y; Lao, J; Tang, Z; Wang, Y; Xu, C; Xu, H; Yin, H, 2023) |
| "Summary-level data for GERD were available from a genome-wide association meta-analysis of 71,522 GERD cases and 261,079 controls of European descent from the UK Biobank and QSkin Sun and Health studies." | 2.82 | Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study. ( Larsson, SC; Yuan, S, 2022) |
| "Caffeine is a common additive to SSB, and through dependence effects, it has the potential to promote the consumption of caffeine-containing foods." | 2.80 | Caffeine increases sugar-sweetened beverage consumption in a free-living population: a randomised controlled trial. ( Keast, RS; Riddell, LJ; Sayompark, D; Swinburn, BA; Whitelock, S, 2015) |
| "Caffeine and ephedrine was an effective combination therapy for weight loss until ephedrine was removed from the market due to safety concerns." | 2.80 | The effect of caffeine and albuterol on body composition and metabolic rate. ( Arceneaux, KP; Chu, JT; Greenway, FL; Jacob, G; Johnson, WD; Liu, AG; Primeaux, SD; Schreiber, AL; Tipton, RC; Yu, Y, 2015) |
| "Body weight reductions were 0." | 2.70 | Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. ( Andersen, T; Fogh, J, 2001) |
| "Treatment with caffeine in amounts equivalent to those found in the green tea extract had no effect on EE and RQ nor on urinary nitrogen or catecholamines." | 2.69 | Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. ( Chantre, P; Dulloo, AG; Duret, C; Fathi, M; Girardier, L; Mensi, N; Rohrer, D; Vandermander, J, 1999) |
| " Adverse events were negligible and did not differ between the CE and PL groups." | 2.69 | Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. ( Erhardt, E; Jeges, S; Molnár, D; Török, K, 2000) |
| "Obesity is a worldwide prevalent metabolic disorder that is associated with diabetes, among many other diseases." | 2.66 | Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO. ( Deng, Y; Papukashvili, D; Rcheulishvili, N, 2020) |
| "Obesity and overweight are major health issues." | 2.53 | A Review of Natural Stimulant and Non-stimulant Thermogenic Agents. ( Badmaev, V; Stohs, SJ, 2016) |
| "The pathophysiology of obesity and type 2 diabetes as well as the necessity of preventive options based on the increasing prevalence of these two disorders worldwide is briefly discussed." | 2.53 | Coffee consumption, obesity and type 2 diabetes: a mini-review. ( Lima, DR; Santos, RM, 2016) |
| "Current drug treatments for obesity produce small and usually unsustainable decreases in body weight with the risk of major adverse effects." | 2.52 | Functional foods as potential therapeutic options for metabolic syndrome. ( Brown, L; Panchal, SK; Poudyal, H, 2015) |
| "Obesity is considered as an independent risk factor for miscarriage, involved in oocyte and embryo quality, but also in endometrial receptivity." | 2.48 | [Nutrition and miscarriages: a literature review]. ( Benammar, A; Cedrin-Durnerin, I; Dupont, C; Faure, C; Hercberg, S; Levy, R; Sermondade, N; Sifer, C, 2012) |
| "Caffeine has also been recently linked to weight loss and consequent reduction of the overall risks for developing the metabolic syndrome." | 2.46 | Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. ( Gonzalez de Mejia, E; Heckman, MA; Weil, J, 2010) |
| "Obesity, non-alcoholic fatty liver and steatohepatitis as well as diabetes mellitus together also form a significant risk for HCC, due to the gradually increasing number of patients." | 2.46 | [Role of environmental factors in the etiology of hepatocellular carcinoma]. ( Tornai, I, 2010) |
| "In a subgroup, migraine evolves into a more protracted condition (migraine transformation or progression)." | 2.45 | Migraine chronification--concept and risk factors. ( Bigal, M, 2009) |
| "Obesity is a serious health problem throughout the world." | 2.41 | Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. ( Bagchi, D; Bagchi, M; DiFerdinando, D; Preuss, HG, 2002) |
| "Obesity is a multifactorial and complex affectation that is characterized by a long-term excess energy intake (EI) above energy expenditure (EE)." | 2.40 | Food intake, energy balance and body weight control. ( Doucet, E; Tremblay, A, 1997) |
| "Obesity is increasing at an alarming rate." | 2.40 | Challenges in obesity management. ( Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS, 1998) |
| "Obesity is characterised by pathophysiological defects affecting both sides of the energy balance equation." | 2.40 | What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice. ( Astrup, A; Lundsgaard, C, 1998) |
| " Long term use produces tolerance to some of the pharmacological effects." | 2.39 | Pharmacological rationale for the clinical use of caffeine. ( Sawynok, J, 1995) |
| " Each of these three modalities--weight control, alcohol restriction, and sodium restriction--was found to be capable not only of independently controlling blood pressure (particularly in patients with mild hypertension) but also of reducing the number and dosage of prescribed pharmacological agents, should their prescription be indicated." | 2.37 | Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. ( , 1986) |
| "Essential hypertension is more prevalent and vascular disease more severe in blacks than in whites." | 2.37 | Risks for arterial hypertension. ( Messerli, FH; Ruddel, H; Schmieder, RE, 1986) |
| "Obesity is a state of accumulating excessive body fat, charactering by a high blood lipid and associating with various metabolic diseases." | 1.91 | Improvement of obesity by Liupao tea is through the IRS-1/PI3K/AKT/GLUT4 signaling pathway according to network pharmacology and experimental verification. ( Ni, W; Teng, C; Wu, Z; Ye, W; Yu, C; Yu, W; Zeng, Y, 2023) |
| "Obesity is an important risk factor for diabetes mellitus (DM) which is a major global health problem." | 1.72 | Effects of Isoprenaline on ventricular myocyte shortening and Ca ( Howarth, FC; Qureshi, MA; Sultan, A, 2022) |
| "Obesity was induced in mice by high-fat diet and the tested compounds (KD-64 and caffeine) were administrated for 21 days." | 1.56 | KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice. ( Bednarski, M; Drabczyńska, A; Dziubina, A; Kieć-Kononowicz, K; Kotańska, M; Mika, K; Reguła, K; Sapa, J; Szafarz, M; Zygmunt, M, 2020) |
| "Obesity was defined as BMI > 30." | 1.42 | Associations between night work and BMI, alcohol, smoking, caffeine and exercise--a cross-sectional study. ( Bjorvatn, B; Buchvold, HV; Pallesen, S; Øyane, NM, 2015) |
| "The treatment with caffeine in the rats fed the high-carbohydrate, high-fat diet decreased body fat and systolic blood pressure, improved glucose tolerance and insulin sensitivity, and attenuated cardiovascular and hepatic abnormalities, although the plasma lipid concentrations were further increased." | 1.38 | Caffeine attenuates metabolic syndrome in diet-induced obese rats. ( Brown, L; Kauter, K; Panchal, SK; Ward, LC; Wong, WY, 2012) |
| "Paroxysmal supraventricular tachycardia (PSVT) on electrocardiographic monitoring was found." | 1.38 | Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard. ( Aćimović, L; Babić, G; Ercegović, GV; Janković, S; Segrt, Z; Vukcević, NP, 2012) |
| " Incorporation of the relevant physiological and biochemical changes into predictive bottom-up pharmacokinetic models in order to optimize dosage regimens may offer a logical way forward for the cases where no clinical data exist." | 1.37 | Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance. ( Aarabi, M; Allabi, AC; Almond, LM; Ghobadi, C; Jamei, M; Johnson, TN; Rostami-Hodjegan, A; Rowland-Yeo, K, 2011) |
| "Metabolic syndrome was defined as the presence of > or = 3 of the following: waist circumference > or = 35 inches (women) or > or = 40 inches (men); fasting blood glucose > or = 100 mg/dL; serum triglycerides > or = 150 mg/dL; blood pressure > or = 135/85 mm Hg; and high-density lipoprotein cholesterol < 40 mg/dL (men) or < 50 mg/dL (women)." | 1.34 | Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. ( D'Agostino, RB; Dhingra, R; Fox, CS; Gaziano, JM; Jacques, PF; Meigs, JB; Sullivan, L; Vasan, RS; Wang, TJ, 2007) |
| " This study suggests that the long-term intake of the dietary supplement inducing CYP1A2 may increase the incidence of colorectal cancers caused by procarcinogens activated by CYP1A2 in rapid N-acetyltransferase-2 acetylators and of lung adenocarcinoma in slow acetylators." | 1.32 | Induction of the procarcinogen-activating CYP1A2 by a herbal dietary supplement in rats and humans. ( Chung, WG; Ryu, SD, 2003) |
| "Ephedrine is a sympathicomimetic agent that stimulates the central nervous and cardiovascular systems and causes bronchodilatation." | 1.31 | [Ephedrine and ephedra in weight loss products and other preparations]. ( Stricker, BH; van der Hooft, CS, 2002) |
| "Low caloric diet is a commonly accepted treatment in obesity." | 1.30 | Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women. ( Hartleb, M; Janusz, M; Karpel, E; Nowak, A; Waluga, M, 1998) |
| "Caffeine treatment showed no effect on the food intake, but decreased the body fat content significantly in obese mice." | 1.29 | Effect of caffeine on the levels of brain serotonin and catecholamine in the genetically obese mice. ( Chen, MD; Ho, LT; Lin, PY; Lin, WH; Song, YM, 1994) |
| " A consistent dose-response was not found, however, by number of cups of decaffeinated coffee consumed per day." | 1.27 | A case-control study of factors affecting the development of renal cell cancer. ( Goodman, MT; Morgenstern, H; Wynder, EL, 1986) |
| " Since clearance of caffeine is not related to body weight, these data indicate that a chronic dosing regimen to maintain a given plasma caffeine concentration should not be altered due to obesity." | 1.27 | Caffeine disposition in obesity. ( Abernethy, DR; Schwartz, JB; Todd, EL, 1985) |
| "Secondly, hypertension is a risk factor for premature cardiovascular morbidity and mortality." | 1.27 | Nutritional and lifestyle approaches to the prevention and management of hypertension. ( Egan, B, 1985) |
Research
Studies (240)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 46 (19.17) | 18.7374 |
| 1990's | 33 (13.75) | 18.2507 |
| 2000's | 61 (25.42) | 29.6817 |
| 2010's | 72 (30.00) | 24.3611 |
| 2020's | 28 (11.67) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ferreira, GA | 1 |
| Wagner, L | 1 |
| Maziero, R | 1 |
| Ataide-Silva, T | 1 |
| Silva, NA | 1 |
| Bertuzzi, R | 1 |
| Lima-Silva, AE | 1 |
| Yuan, S | 1 |
| Larsson, SC | 1 |
| Narayan, VP | 1 |
| Yoon, SY | 1 |
| Yu, L | 1 |
| Mei, H | 1 |
| Shi, D | 1 |
| Wang, X | 1 |
| Cheng, M | 1 |
| Fan, L | 1 |
| Xiao, Y | 1 |
| Liang, R | 1 |
| Wang, B | 1 |
| Yang, M | 1 |
| Chen, W | 1 |
| Saimaiti, A | 1 |
| Zhou, DD | 1 |
| Li, J | 2 |
| Xiong, RG | 1 |
| Gan, RY | 1 |
| Huang, SY | 1 |
| Shang, A | 1 |
| Zhao, CN | 1 |
| Li, HY | 1 |
| Li, HB | 1 |
| Qu, W | 1 |
| Chen, Z | 2 |
| Hu, X | 2 |
| Zou, T | 1 |
| Huang, Y | 3 |
| Zhang, Y | 2 |
| Hu, Y | 1 |
| Tian, S | 1 |
| Wan, J | 1 |
| Liao, R | 1 |
| Bai, L | 1 |
| Xue, J | 1 |
| Ding, Y | 1 |
| Hu, M | 1 |
| Zhang, XJ | 1 |
| Zhang, X | 1 |
| Zhao, J | 1 |
| Cheng, X | 1 |
| She, ZG | 1 |
| Li, H | 1 |
| Pavão, TP | 1 |
| Chemello, D | 1 |
| Ferigollo, A | 1 |
| Saffi, MAL | 1 |
| Moresco, RN | 1 |
| Stein, CDS | 1 |
| Emanuelli, T | 1 |
| Somacal, S | 1 |
| Moriguchi, EH | 1 |
| Badimon, L | 1 |
| Chagas, P | 1 |
| Sultan, A | 1 |
| Qureshi, MA | 1 |
| Howarth, FC | 1 |
| Gleason, JL | 1 |
| Sundaram, R | 1 |
| Mitro, SD | 1 |
| Hinkle, SN | 1 |
| Gilman, SE | 1 |
| Zhang, C | 1 |
| Newman, RB | 1 |
| Hunt, KJ | 1 |
| Skupski, DW | 1 |
| Grobman, WA | 1 |
| Nageotte, M | 1 |
| Robinson, M | 1 |
| Kannan, K | 1 |
| Grantz, KL | 1 |
| Zhao, YC | 1 |
| Li, LP | 1 |
| Li, XY | 1 |
| Wang, CC | 1 |
| Yang, JY | 1 |
| Xue, CH | 1 |
| Wang, YM | 1 |
| Zhang, TT | 1 |
| Wu, Z | 1 |
| Yu, W | 1 |
| Ni, W | 1 |
| Teng, C | 1 |
| Ye, W | 1 |
| Yu, C | 1 |
| Zeng, Y | 1 |
| Alhadi, IA | 1 |
| Al Ansari, AM | 1 |
| AlSaleh, AFF | 1 |
| Alabbasi, AMA | 1 |
| Yuan, Y | 1 |
| He, J | 1 |
| Tang, M | 1 |
| Chen, H | 1 |
| Wei, T | 1 |
| Zhang, B | 1 |
| Liang, D | 1 |
| Nie, X | 1 |
| Henn, M | 1 |
| Babio, N | 1 |
| Romaguera, D | 1 |
| Vázquez-Ruiz, Z | 1 |
| Konieczna, J | 1 |
| Vioque, J | 1 |
| Torres-Collado, L | 1 |
| Razquin, C | 1 |
| Buil-Cosiales, P | 1 |
| Fitó, M | 1 |
| Schröder, H | 1 |
| Hu, FB | 2 |
| Abete, I | 1 |
| Zulet, MÁ | 1 |
| Fernández-Villa, T | 1 |
| Martín, V | 1 |
| Estruch, R | 1 |
| Vidal, J | 1 |
| Paz-Graniel, I | 1 |
| Martínez, JA | 1 |
| Salas-Salvadó, J | 1 |
| Martínez-González, MA | 1 |
| Ruiz-Canela, M | 1 |
| Yehuda, H | 1 |
| Madrer, N | 1 |
| Goldberg, D | 1 |
| Soreq, H | 1 |
| Meerson, A | 1 |
| Che, H | 1 |
| Wang, Y | 1 |
| Lao, J | 1 |
| Deng, Y | 2 |
| Xu, C | 1 |
| Yin, H | 1 |
| Tang, Z | 1 |
| Xu, H | 1 |
| Uner, B | 1 |
| Macit Celebi, MS | 1 |
| Permyakova, A | 1 |
| Rothner, A | 1 |
| Knapp, S | 1 |
| Nemirovski, A | 1 |
| Ben-Zvi, D | 1 |
| Tam, J | 1 |
| Alshahrani, SH | 1 |
| Atia, YA | 1 |
| Badir, RA | 1 |
| Almalki, SG | 1 |
| Tayyib, NA | 1 |
| Shahab, S | 1 |
| Romero-Parra, RM | 1 |
| Abid, MK | 1 |
| Hussien, BM | 1 |
| Ramaiah, P | 1 |
| Xu, M | 1 |
| Yang, L | 2 |
| Zhu, Y | 2 |
| Liao, M | 1 |
| Chu, L | 1 |
| Li, X | 1 |
| Lin, L | 1 |
| Zheng, G | 2 |
| Papukashvili, D | 1 |
| Rcheulishvili, N | 1 |
| Alkhatib, A | 1 |
| Hsieh, MJ | 1 |
| Kuo, CH | 1 |
| Hou, CW | 1 |
| Kotańska, M | 1 |
| Dziubina, A | 1 |
| Szafarz, M | 1 |
| Mika, K | 1 |
| Reguła, K | 1 |
| Bednarski, M | 1 |
| Zygmunt, M | 1 |
| Drabczyńska, A | 1 |
| Sapa, J | 1 |
| Kieć-Kononowicz, K | 1 |
| Zhong, S | 1 |
| Jing, N | 1 |
| Liu, X | 1 |
| Jin, M | 1 |
| Yang, X | 1 |
| Li, C | 1 |
| Zhao, K | 1 |
| Sylvetsky, AC | 1 |
| Visek, AJ | 1 |
| Halberg, S | 1 |
| Rhee, DK | 1 |
| Ongaro, Z | 1 |
| Essel, KD | 1 |
| Dietz, WH | 1 |
| Sacheck, J | 1 |
| Zhu, MZ | 2 |
| Zhou, F | 1 |
| Ouyang, J | 1 |
| Wang, QY | 1 |
| Li, YL | 1 |
| Wu, JL | 1 |
| Huang, JA | 2 |
| Liu, ZH | 2 |
| Bodur, M | 1 |
| Baspinar, B | 1 |
| Özçelik, AÖ | 1 |
| Dangol, M | 1 |
| Kim, S | 1 |
| Li, CG | 1 |
| Fakhraei Lahiji, S | 1 |
| Jang, M | 1 |
| Ma, Y | 1 |
| Huh, I | 1 |
| Jung, H | 1 |
| Faghfoori, Z | 1 |
| Fazelian, S | 1 |
| Shadnoush, M | 1 |
| Goodarzi, R | 1 |
| Gomez-Zorita, S | 1 |
| Belles, C | 1 |
| Briot, A | 1 |
| Fernández-Quintela, A | 1 |
| Portillo, MP | 1 |
| Carpéné, C | 1 |
| Wu, L | 1 |
| Meng, J | 1 |
| Shen, Q | 1 |
| Pan, S | 1 |
| Zhu, LQ | 1 |
| Lu, Y | 1 |
| Zhang, G | 1 |
| Macedo, RC | 1 |
| Bondan, EF | 1 |
| Otton, R | 2 |
| Gökcen, BB | 1 |
| Şanlier, N | 1 |
| Liu, CW | 1 |
| Tsai, HC | 1 |
| Huang, CC | 1 |
| Tsai, CY | 1 |
| Su, YB | 1 |
| Lin, MW | 1 |
| Lee, KC | 1 |
| Hsieh, YC | 1 |
| Li, TH | 1 |
| Huang, SF | 1 |
| Yang, YY | 1 |
| Hou, MC | 1 |
| Lin, HC | 1 |
| Lee, FY | 1 |
| Lee, SD | 1 |
| Köhn, FM | 1 |
| Schuppe, HC | 1 |
| Kawada, T | 1 |
| Viner, R | 1 |
| Nishitsuji, K | 1 |
| Watanabe, S | 1 |
| Xiao, J | 1 |
| Nagatomo, R | 1 |
| Ogawa, H | 1 |
| Tsunematsu, T | 1 |
| Umemoto, H | 1 |
| Morimoto, Y | 1 |
| Akatsu, H | 1 |
| Inoue, K | 1 |
| Tsuneyama, K | 1 |
| Escalante, G | 1 |
| Bryan, P | 1 |
| Rodriguez, J | 1 |
| Jayawardena, R | 1 |
| Sooriyaarachchi, P | 1 |
| Ranasinghe, P | 1 |
| Perera, A | 1 |
| Hills, AP | 1 |
| Yang, Z | 1 |
| Zhang, YB | 1 |
| Wen, BB | 1 |
| An, HM | 1 |
| Ou, XC | 1 |
| Xiong, YF | 1 |
| Lin, HY | 1 |
| Chen, LW | 1 |
| Murrin, CM | 1 |
| Mehegan, J | 1 |
| Kelleher, CC | 1 |
| Phillips, CM | 1 |
| Gavrieli, A | 2 |
| Fragopoulou, E | 2 |
| Mantzoros, CS | 2 |
| Yannakoulia, M | 2 |
| Karfopoulou, E | 1 |
| Kardatou, E | 1 |
| Spyreli, E | 1 |
| Liu, AG | 2 |
| Smith, SR | 5 |
| Fujioka, K | 1 |
| Greenway, FL | 8 |
| Uccella, S | 1 |
| Mariani, A | 1 |
| Wang, AH | 1 |
| Vierkant, RA | 1 |
| Cliby, WA | 1 |
| Robien, K | 1 |
| Anderson, KE | 1 |
| Cerhan, JR | 1 |
| Bhatti, SK | 1 |
| O'Keefe, JH | 1 |
| Lavie, CJ | 1 |
| Hursel, R | 3 |
| Westerterp-Plantenga, MS | 7 |
| Sturtz, LA | 1 |
| Melley, J | 1 |
| Mamula, K | 1 |
| Shriver, CD | 1 |
| Ellsworth, RE | 1 |
| Kim, J | 2 |
| Shim, J | 1 |
| Lee, CY | 1 |
| Lee, KW | 1 |
| Lee, HJ | 1 |
| Cowan, TE | 1 |
| Palmnäs, MS | 1 |
| Yang, J | 1 |
| Bomhof, MR | 1 |
| Ardell, KL | 1 |
| Reimer, RA | 1 |
| Vogel, HJ | 1 |
| Shearer, J | 2 |
| Yamashita, Y | 1 |
| Wang, L | 2 |
| Tanaka, Y | 1 |
| Zhang, T | 1 |
| Ashida, H | 1 |
| Owens, J | 1 |
| Ramin, C | 1 |
| Devore, EE | 1 |
| Wang, W | 1 |
| Pierre-Paul, J | 1 |
| Wegrzyn, LR | 1 |
| Schernhammer, ES | 1 |
| Ohara, T | 2 |
| Muroyama, K | 2 |
| Yamamoto, Y | 2 |
| Murosaki, S | 2 |
| Cho, SJ | 1 |
| Chu, MK | 1 |
| Xu, Y | 1 |
| Zhang, M | 1 |
| Wu, T | 1 |
| Dai, S | 1 |
| Xu, J | 1 |
| Zhou, Z | 1 |
| Bajerska, J | 1 |
| Mildner-Szkudlarz, S | 1 |
| Walkowiak, J | 1 |
| Keast, RS | 2 |
| Swinburn, BA | 2 |
| Sayompark, D | 2 |
| Whitelock, S | 1 |
| Riddell, LJ | 2 |
| Klebanoff, MA | 1 |
| Keim, SA | 1 |
| Kim, HY | 1 |
| Lee, MY | 1 |
| Park, HM | 1 |
| Park, YK | 1 |
| Shon, JC | 1 |
| Liu, KH | 1 |
| Lee, CH | 1 |
| Lopez, DS | 1 |
| Wang, R | 1 |
| Tsilidis, KK | 1 |
| Zhu, H | 1 |
| Daniel, CR | 1 |
| Sinha, A | 1 |
| Canfield, S | 1 |
| Arceneaux, KP | 1 |
| Chu, JT | 1 |
| Jacob, G | 1 |
| Schreiber, AL | 1 |
| Tipton, RC | 1 |
| Yu, Y | 1 |
| Johnson, WD | 1 |
| Primeaux, SD | 1 |
| Brown, L | 2 |
| Poudyal, H | 1 |
| Panchal, SK | 2 |
| Rocha, A | 1 |
| Bolin, AP | 1 |
| Cardoso, CA | 1 |
| Buchvold, HV | 1 |
| Pallesen, S | 1 |
| Øyane, NM | 1 |
| Bjorvatn, B | 1 |
| Dostal, AM | 2 |
| Samavat, H | 1 |
| Espejo, L | 2 |
| Arikawa, AY | 1 |
| Stendell-Hollis, NR | 1 |
| Kurzer, MS | 2 |
| Arikawa, A | 1 |
| Aragonès, G | 1 |
| Ardid-Ruiz, A | 1 |
| Ibars, M | 1 |
| Suárez, M | 1 |
| Bladé, C | 1 |
| Stohs, SJ | 2 |
| Badmaev, V | 1 |
| Santos, RM | 1 |
| Lima, DR | 1 |
| Graham, TE | 4 |
| Skinner, TL | 1 |
| Lean, ME | 1 |
| Te Morenga, L | 1 |
| Harpaz, E | 1 |
| Tamir, S | 1 |
| Weinstein, A | 1 |
| Weinstein, Y | 1 |
| Levy, Y | 1 |
| Narotzki, B | 1 |
| Reznick, AZ | 1 |
| Bortolotti, M | 1 |
| Rudelle, S | 1 |
| Schneiter, P | 1 |
| Vidal, H | 1 |
| Loizon, E | 1 |
| Tappy, L | 1 |
| Acheson, KJ | 2 |
| Yun, JW | 1 |
| Shin, ES | 1 |
| Cho, SY | 1 |
| Kim, SH | 1 |
| Kim, CW | 1 |
| Lee, TR | 1 |
| Kim, BH | 1 |
| Bray, GA | 3 |
| Brown, CM | 1 |
| Dulloo, AG | 13 |
| Montani, JP | 1 |
| Wang, S | 1 |
| Sparks, LM | 1 |
| Xie, H | 1 |
| de Jonge, L | 2 |
| Bigal, ME | 1 |
| Lipton, RB | 1 |
| Richard, D | 1 |
| Kefi, K | 1 |
| Barbe, U | 1 |
| Poli, A | 1 |
| Bausero, P | 1 |
| Visioli, F | 1 |
| Belza, A | 3 |
| Gille, MB | 1 |
| Schultz John, S | 1 |
| Kondrup, J | 2 |
| Viechtbauer, W | 1 |
| Bloomer, RJ | 1 |
| Canale, RE | 1 |
| Blankenship, MM | 1 |
| Hammond, KG | 1 |
| Fisher-Wellman, KH | 1 |
| Schilling, BK | 1 |
| Bigal, M | 1 |
| Thielecke, F | 1 |
| Rahn, G | 1 |
| Böhnke, J | 1 |
| Adams, F | 1 |
| Birkenfeld, AL | 1 |
| Jordan, J | 1 |
| Boschmann, M | 1 |
| Heckman, MA | 1 |
| Weil, J | 1 |
| Gonzalez de Mejia, E | 1 |
| Tornai, I | 1 |
| Swithers, SE | 1 |
| Martin, AA | 1 |
| Clark, KM | 1 |
| Laboy, AF | 1 |
| Davidson, TL | 1 |
| Smith, AE | 1 |
| Lockwood, CM | 1 |
| Moon, JR | 1 |
| Kendall, KL | 1 |
| Fukuda, DH | 1 |
| Tobkin, SE | 1 |
| Cramer, JT | 1 |
| Stout, JR | 1 |
| Rains, TM | 1 |
| Agarwal, S | 1 |
| Maki, KC | 1 |
| Chiney, MS | 1 |
| Schwarzenberg, SJ | 1 |
| Johnson, LA | 1 |
| Roure, R | 1 |
| Oddos, T | 1 |
| Rossi, A | 1 |
| Vial, F | 1 |
| Bertin, C | 1 |
| Sacks, G | 1 |
| Andreazzi, AE | 1 |
| Grassiolli, S | 1 |
| Marangon, PB | 1 |
| Martins, AG | 1 |
| de Oliveira, JC | 1 |
| Torrezan, R | 1 |
| Gravena, C | 1 |
| Garcia, RM | 1 |
| Mathias, PC | 1 |
| Drescher, AA | 1 |
| Goodwin, JL | 1 |
| Silva, GE | 1 |
| Quan, SF | 1 |
| Peña, MM | 1 |
| Taveras, EM | 1 |
| Frisoli, TM | 1 |
| Schmieder, RE | 3 |
| Grodzicki, T | 1 |
| Messerli, FH | 3 |
| Ghobadi, C | 1 |
| Johnson, TN | 1 |
| Aarabi, M | 1 |
| Almond, LM | 1 |
| Allabi, AC | 1 |
| Rowland-Yeo, K | 1 |
| Jamei, M | 1 |
| Rostami-Hodjegan, A | 1 |
| Celec, P | 1 |
| Benammar, A | 1 |
| Sermondade, N | 1 |
| Faure, C | 1 |
| Dupont, C | 1 |
| Cedrin-Durnerin, I | 1 |
| Sifer, C | 1 |
| Hercberg, S | 1 |
| Levy, R | 1 |
| Oi, Y | 1 |
| Hou, IC | 1 |
| Fujita, H | 1 |
| Yazawa, K | 1 |
| Wong, WY | 1 |
| Kauter, K | 1 |
| Ward, LC | 1 |
| Vukcević, NP | 1 |
| Babić, G | 1 |
| Segrt, Z | 1 |
| Ercegović, GV | 1 |
| Janković, S | 1 |
| Aćimović, L | 1 |
| Gosselin, C | 1 |
| Haman, F | 1 |
| Marcason, W | 1 |
| van der Hooft, CS | 1 |
| Stricker, BH | 1 |
| Kalman, D | 1 |
| Incledon, T | 1 |
| Gaunaurd, I | 1 |
| Schwartz, H | 1 |
| Krieger, D | 1 |
| Richelsen, B | 2 |
| Kerr, D | 1 |
| James, J | 1 |
| Astrup, AV | 2 |
| von Eyben, FE | 1 |
| Ryu, SD | 1 |
| Chung, WG | 1 |
| Preuss, HG | 1 |
| DiFerdinando, D | 1 |
| Bagchi, M | 1 |
| Bagchi, D | 1 |
| Zimmerman, E | 1 |
| Wylie-Rosett, J | 1 |
| KUFTINEC, DM | 1 |
| MAYER, J | 1 |
| Kovacs, EM | 3 |
| Lejeune, MP | 2 |
| Nijs, I | 1 |
| Petrie, HJ | 1 |
| Chown, SE | 1 |
| Belfie, LM | 1 |
| Duncan, AM | 1 |
| McLaren, DH | 2 |
| Conquer, JA | 1 |
| Blanchard, D | 1 |
| Frisard, M | 1 |
| Coffey, CS | 1 |
| Steiner, D | 1 |
| Baker, BA | 1 |
| Allison, DB | 1 |
| Robinson, LE | 1 |
| Savani, S | 1 |
| Battram, DS | 1 |
| Sathasivam, P | 1 |
| Ingerslev, J | 1 |
| Svendsen, TL | 1 |
| Mørk, A | 1 |
| Han, LK | 2 |
| Kai, F | 1 |
| Okuda, H | 2 |
| Ruhl, CE | 1 |
| Everhart, JE | 1 |
| Lee, S | 1 |
| Hudson, R | 1 |
| Kilpatrick, K | 1 |
| Ross, R | 1 |
| Jessen, AB | 1 |
| Kobayashi-Hattori, K | 1 |
| Mogi, A | 1 |
| Matsumoto, Y | 1 |
| Takita, T | 1 |
| Hughes, TA | 1 |
| Stentz, F | 1 |
| Gettys, T | 1 |
| Mela, DJ | 1 |
| DeWald, T | 1 |
| Khaodhiar, L | 1 |
| Donahue, MP | 1 |
| Blackburn, G | 1 |
| Lopez-Garcia, E | 1 |
| van Dam, RM | 1 |
| Rajpathak, S | 1 |
| Willett, WC | 1 |
| Manson, JE | 1 |
| Hackman, RM | 1 |
| Havel, PJ | 1 |
| Schwartz, HJ | 1 |
| Rutledge, JC | 1 |
| Watnik, MR | 1 |
| Noceti, EM | 1 |
| Stern, JS | 1 |
| Keen, CL | 1 |
| Frandsen, E | 1 |
| Rush, E | 1 |
| Schulz, S | 1 |
| Obolonkin, V | 1 |
| Simmons, D | 1 |
| Plank, L | 1 |
| Miura, K | 1 |
| Nakagawa, H | 1 |
| Ueshima, H | 1 |
| Okayama, A | 1 |
| Saitoh, S | 1 |
| Curb, JD | 1 |
| Rodriguez, BL | 1 |
| Sakata, K | 1 |
| Okuda, N | 1 |
| Yoshita, K | 1 |
| Stamler, J | 1 |
| Kelly-Weeder, S | 1 |
| O'Connor, A | 1 |
| Diepvens, K | 1 |
| Westerterp, KR | 1 |
| Twiss, JJ | 1 |
| Gross, GJ | 1 |
| Waltman, NL | 1 |
| Ott, CD | 1 |
| Lindsey, AM | 1 |
| Lupi, O | 1 |
| Semenovitch, IJ | 1 |
| Treu, C | 1 |
| Bottino, D | 1 |
| Bouskela, E | 1 |
| Dhingra, R | 1 |
| Sullivan, L | 1 |
| Jacques, PF | 1 |
| Wang, TJ | 1 |
| Fox, CS | 1 |
| Meigs, JB | 1 |
| D'Agostino, RB | 1 |
| Gaziano, JM | 1 |
| Vasan, RS | 1 |
| Tofovic, SP | 3 |
| Salah, EM | 1 |
| Jackson, EK | 3 |
| Melhem, M | 1 |
| Reba-Harrelson, L | 1 |
| Von Holle, A | 1 |
| Thornton, LM | 1 |
| Klump, KL | 1 |
| Berrettini, WH | 1 |
| Brandt, H | 1 |
| Crawford, S | 1 |
| Crow, S | 1 |
| Fichter, MM | 1 |
| Goldman, D | 1 |
| Halmi, KA | 1 |
| Johnson, C | 1 |
| Kaplan, AS | 1 |
| Keel, P | 1 |
| LaVia, M | 1 |
| Mitchell, J | 1 |
| Plotnicov, K | 1 |
| Rotondo, A | 1 |
| Strober, M | 1 |
| Treasure, J | 1 |
| Woodside, DB | 1 |
| Kaye, WH | 1 |
| Bulik, CM | 1 |
| Drew, R | 1 |
| Altschuler, S | 1 |
| Conte, A | 1 |
| Sebok, M | 1 |
| Marlin, RL | 1 |
| Winick, C | 1 |
| Bukowiecki, LJ | 1 |
| Lupien, J | 1 |
| Folléa, N | 1 |
| Jahjah, L | 1 |
| Thomas, J | 2 |
| Neser, WB | 1 |
| Semenya, K | 1 |
| Green, DR | 1 |
| Jung, RT | 1 |
| Shetty, PS | 1 |
| James, WP | 1 |
| Barrand, MA | 1 |
| Callingham, BA | 1 |
| Pena, M | 2 |
| Barta, L | 2 |
| Simon, G | 1 |
| Regöly-Mérei, A | 2 |
| Tichy, M | 2 |
| Bedö, M | 2 |
| Koltai, G | 1 |
| Malchow-Møller, A | 1 |
| Larsen, S | 1 |
| Hey, H | 1 |
| Stokholm, KH | 1 |
| Juhl, E | 1 |
| Quaade, F | 6 |
| Pleuss, J | 1 |
| Kochar, MS | 1 |
| Zahorska-Markiewicz, B | 2 |
| Pittet, P | 1 |
| Anantharaman, K | 1 |
| Jéquier, E | 4 |
| Bracco, D | 1 |
| Ferrarra, JM | 1 |
| Arnaud, MJ | 1 |
| Schutz, Y | 1 |
| Caraco, Y | 1 |
| Zylber-Katz, E | 1 |
| Berry, EM | 1 |
| Levy, M | 1 |
| Sawynok, J | 1 |
| Chen, MD | 1 |
| Lin, WH | 1 |
| Song, YM | 1 |
| Lin, PY | 1 |
| Ho, LT | 1 |
| Buemann, B | 2 |
| Marckmann, P | 1 |
| Christensen, NJ | 3 |
| Astrup, A | 8 |
| Yoshida, T | 1 |
| Sakane, N | 1 |
| Umekawa, T | 1 |
| Kondo, M | 1 |
| Toubro, S | 6 |
| Breum, L | 5 |
| Pedersen, JK | 1 |
| Ahlstrøm, F | 1 |
| Frimodt-Møller, J | 1 |
| Nakanishi, T | 1 |
| Yoshimura, M | 1 |
| Pasquali, R | 1 |
| Casimirri, F | 1 |
| Daly, PA | 2 |
| Krieger, DR | 2 |
| Young, JB | 2 |
| Landsberg, L | 2 |
| Horton, TJ | 1 |
| Geissler, CA | 2 |
| Cipriani, F | 1 |
| Geddes, M | 1 |
| Doucet, E | 1 |
| Tremblay, A | 1 |
| Waluga, M | 1 |
| Janusz, M | 1 |
| Karpel, E | 1 |
| Hartleb, M | 1 |
| Nowak, A | 1 |
| Ramsey, JJ | 1 |
| Colman, RJ | 1 |
| Swick, AG | 1 |
| Kemnitz, JW | 1 |
| Poston, WS | 1 |
| Foreyt, JP | 1 |
| Borrell, L | 1 |
| Haddock, CK | 1 |
| Lundsgaard, C | 1 |
| Takaku, T | 1 |
| Kimura, Y | 1 |
| Misra, T | 1 |
| Gilchrist, JS | 1 |
| Russell, JC | 1 |
| Pierce, GN | 1 |
| Bondi, M | 1 |
| Grugni, G | 1 |
| Velardo, A | 1 |
| Biella, O | 1 |
| Venneri, MG | 1 |
| Morabito, F | 1 |
| Menozzi, R | 1 |
| Rio, GD | 1 |
| Ryan, DH | 1 |
| Rood, JC | 1 |
| Tucker, EW | 1 |
| Duret, C | 1 |
| Rohrer, D | 1 |
| Girardier, L | 3 |
| Mensi, N | 1 |
| Fathi, M | 1 |
| Chantre, P | 2 |
| Vandermander, J | 2 |
| Seydoux, J | 2 |
| Molnár, D | 1 |
| Török, K | 1 |
| Erhardt, E | 1 |
| Jeges, S | 1 |
| Raum, WJ | 1 |
| DeLany, JP | 1 |
| Boozer, CN | 1 |
| Nasser, JA | 1 |
| Heymsfield, SB | 1 |
| Wang, V | 1 |
| Chen, G | 1 |
| Solomon, JL | 1 |
| Kusaka, H | 1 |
| Bastacky, SI | 2 |
| Andersen, T | 1 |
| Fogh, J | 1 |
| Wahlqvist, ML | 1 |
| Wattanapenpaiboon, N | 1 |
| Ahmed, M | 1 |
| Grapengiesser, E | 1 |
| Tormey, WP | 1 |
| Bruzzi, A | 1 |
| Beilin, LJ | 1 |
| Burke, V | 1 |
| Puddey, IB | 1 |
| Mori, TA | 1 |
| Hodgson, JM | 1 |
| Kost, CK | 1 |
| Cohen, S | 2 |
| Griboff, SI | 1 |
| Berman, R | 1 |
| Ratzmann, KP | 1 |
| Riemer, D | 1 |
| Männchen, E | 1 |
| Paul, I | 1 |
| Oberman, Z | 1 |
| Herzberg, M | 1 |
| Jaskolka, H | 1 |
| Harell, A | 1 |
| Hoerer, E | 1 |
| Laurian, L | 1 |
| Hein, P | 1 |
| Thorbek, G | 1 |
| Victor, OJ | 1 |
| Ransil, BJ | 1 |
| Lowell, BB | 1 |
| Napolitano, A | 1 |
| Usher, P | 1 |
| Rosen, BS | 1 |
| Spiegelman, BM | 1 |
| Flier, JS | 1 |
| Tulp, OL | 1 |
| Buck, CL | 1 |
| Horton, T | 1 |
| Collins, A | 1 |
| Miller, DS | 6 |
| Cooper, GR | 1 |
| Myers, GL | 1 |
| Smith, SJ | 1 |
| Sampson, EJ | 1 |
| Garavaglia, G | 1 |
| Ruddel, H | 2 |
| Baron, JA | 1 |
| Adams, P | 1 |
| Ward, M | 1 |
| Martínez, A | 1 |
| Izquierdo, R | 1 |
| Balanzategui, I | 1 |
| La Vecchia, C | 1 |
| Franceschi, S | 1 |
| Decarli, A | 1 |
| Pampallona, S | 1 |
| Tognoni, G | 1 |
| Goodman, MT | 1 |
| Morgenstern, H | 1 |
| Wynder, EL | 1 |
| Kamimori, GH | 1 |
| Somani, SM | 1 |
| Knowlton, RG | 1 |
| Perkins, RM | 1 |
| Pedersen, O | 1 |
| Huttunen, JK | 1 |
| Pietinen, P | 1 |
| Nissinen, A | 1 |
| Puska, P | 1 |
| Abernethy, DR | 1 |
| Todd, EL | 1 |
| Schwartz, JB | 1 |
| Egan, B | 1 |
| Ogston, D | 1 |
| Enser, M | 1 |
| Mulli, JC | 1 |
| Weber, I | 1 |
| Fabre, J | 1 |
| Guy-Grand, B | 1 |
| Dorf, G | 1 |
| Duchier, J | 1 |
| Aimez, P | 1 |
| Ruckhäberle, B | 1 |
| Ries, W | 1 |
| Junod, A | 1 |
| Letarte, J | 1 |
| Lambert, AE | 1 |
| Stauffacher, W | 1 |
| Ruedi, B | 1 |
| Borel, GA | 1 |
| Graziano, M | 1 |
| Frei, J | 1 |
| Magnenat, P | 1 |
Clinical Trials (17)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Different Amounts of Coffee on Dietary Intake, Appetite-related Feeling, Appetite Hormones, Glucose Metabolism and Inflammatory Markers of Normal Weight and Overweight/Obese Individuals[NCT01495754] | 33 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
| The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man[NCT01710722] | 45 participants (Actual) | Interventional | 2001-02-28 | Completed | |||
| Placebo Controlled, Randomized, Single Blinded Trial on the Effects of Greenselect Phytosome® on Weight Maintenance in Obese Women After a 3-month Weight Loss Intervention[NCT02542449] | Phase 4 | 40 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Effect on Body Composition With Albuterol and Caffeine Versus Placebo in Adolescents: A Pilot Study[NCT02740660] | 12 participants (Actual) | Interventional | 2016-04-30 | Completed | |||
| Phase II, Randomized,Double-blind, Placebo-controlled, Study of the Efficacy of Green Tea Extract on Biomarkers of Breast Cancer Risk in High Risk Women With Differing Catechol-O-methyl Transferase (COMT) Genotypes[NCT00917735] | Phase 2 | 1,075 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of a Weight Management Program on Body Weight in Individuals Who Are Overweight and Otherwise Healthy[NCT04107155] | 54 participants (Actual) | Interventional | 2019-07-23 | Completed | |||
| A Randomized Controlled Trial to Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain in Overweight But Generally Healthy Adults Over the Winter Holiday Period[NCT03372109] | 23 participants (Actual) | Interventional | 2017-11-14 | Completed | |||
| Uncovering the 'ORIGINS' of Diabetes[NCT02226640] | 80 participants (Actual) | Observational | 2010-11-30 | Completed | |||
| The Effect of Green Tea Supplementation Strategies on Fat Oxidation and Body Composition in Overweight Individuals[NCT04628624] | 30 participants (Actual) | Interventional | 2018-12-01 | Completed | |||
| Long-term Effects of Green Tea on Gut Flora, Fat Absorption, Body Composition and Resting Energy Expenditure[NCT01556321] | 70 participants (Actual) | Interventional | 2012-06-30 | Completed | |||
| Effect of Coffee and Tea Consumption on Adolescent Weight Control - a Randomized Clinical Trial[NCT05181176] | 63 participants (Anticipated) | Interventional | 2021-01-01 | Recruiting | |||
| The Effect of Metabolism-Boosting Beverages on 24 Hr Energy Expenditure[NCT01029236] | 30 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| Prevention of Osteoporosis in Breast Cancer Survivors[NCT00567606] | 249 participants (Actual) | Interventional | 2002-04-01 | Completed | |||
| Evaluation of Diet and Treatment With a Combination of Ephedrine and Caffeine on Thermogenesis, Cardiac Function and on Uncoupling Proteins Expression in Adipose and Muscle Tissue of Morbid Obese Patients Undergoing Bariatric Surgery.[NCT02048215] | Phase 3 | 13 participants (Actual) | Interventional | 2000-02-29 | Completed | ||
| Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men[NCT02751840] | Phase 3 | 33 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| A Double-Blind, Randomized, Crossover Study to Examine the Thermogenic Effect of an Energy Drink in Healthy Adults[NCT05061797] | 30 participants (Actual) | Interventional | 2021-08-23 | Completed | |||
| A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss[NCT00692731] | 132 participants (Actual) | Observational | 2006-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Trial Outcomes
Change in Fat Mass With Caffeine/Albuterol
DXA Scan of obese adolescents (NCT02740660)
Timeframe: Baseline, Week 8
| Intervention | kg (Mean) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 0.97 |
| Placebo | -0.21 |
Change in Lean Mass With Caffeine/Albuterol
DXA Scan of obese adolescents (NCT02740660)
Timeframe: Baseline, Week 8
| Intervention | kg (Mean) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 1.34 |
| Placebo | 0.88 |
Change in Weight With Caffeine/Albuterol
(NCT02740660)
Timeframe: Baseline, Week 8
| Intervention | kg (Mean) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 2.57 |
| Placebo | 1.05 |
Number of Participants With Adverse Events
(NCT02740660)
Timeframe: Week 2, Week 4, Week 6, Week 8
| Intervention | Participants (Count of Participants) |
|---|---|
| Caffeine 100mg / Albuterol 4mg | 5 |
| Placebo | 2 |
Circulating Concentrations of IGF Axis Proteins Including IGF-1 and IGFBP-3
Circulating levels of IGF-1 and IGFBP-3 were measured in fasting blood samples by ELISA method. (NCT00917735)
Timeframe: Baseline and month 12
| Intervention | ng/ml (Geometric Mean) | |||
|---|---|---|---|---|
| Circulating IGF-1 at baseline | Circulating IGF-1 at month 12 | Circulating IGFBP-3 at baseline | Circulating IGFBP-3 at month 12 | |
| Green Tea Extract | 87.5 | 83.7 | 2048.0 | 2048.1 |
| Sugar Pill | 88.3 | 83.1 | 2047.6 | 2040.7 |
Circulating Concentrations of Reproductive Hormones Including Estrone, Estradiol, Androstenedione, Testosterone, and Sex Hormone Binding Globulin (SHBG)
Circulating levels of reproductive hormones including estrone, estradiol, androstenedione, testosterone and SHBG were measured in fasting blood samples by liquid chromatography/tandem mass spectrometry method. (NCT00917735)
Timeframe: Baseline and month 12
| Intervention | pg/ml (Geometric Mean) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Circulating estrone at baseline | Circulating estrone at month 12 | Circulating estradiol at baseline | Circulating estradiol at month 12 | Circulating androstenedione at baseline | Circulating androstenedione at month 12 | Circulating testosterone at baseline | Circulating testosterone at month 12 | Circulating SHBG at baseline | Circulating SHBG at month 12 | |
| Green Tea Extract | 22.8 | 22.5 | 3.4 | 3.7 | 479.8 | 468.8 | 151.0 | 158.1 | 68.1 | 68.7 |
| Sugar Pill | 23.6 | 22.4 | 3.7 | 3.1 | 507.2 | 479.5 | 161.6 | 155.1 | 69.1 | 68.7 |
Mammographic Density
Percent mammographic density was measured on digital images using a computer-assisted and quantitative method. (NCT00917735)
Timeframe: Baseline and month 12
| Intervention | Percent (Geometric Mean) | |
|---|---|---|
| Percent mammographic density at baseline | Percent mammographic density at month 12 | |
| Green Tea Extract | 22.71 | 22.09 |
| Sugar Pill | 21.84 | 21.13 |
Reviews
57 reviews available for caffeine and Obesity
| Article | Year |
|---|---|
Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study.
Topics: Adiposity; Body Mass Index; Caffeine; Coffee; Diabetes Mellitus, Type 2; Gastroesophageal Reflux; Ge | 2022 |
Dietary sources, health benefits, and risks of caffeine.
Topics: Adolescent; Caffeine; Child; Diabetes Mellitus; Diet; Female; Humans; Migraine Disorders; Obesity; P | 2023 |
Systematic review of the effect of caffeine therapy effect on cardiometabolic markers in rat models of the metabolic syndrome.
Topics: Animals; Caffeine; Hypertension; Insulin Resistance; Metabolic Syndrome; Obesity; Rats | 2023 |
Role of purinergic signalling in obesity-associated end-organ damage: focus on the effects of natural plant extracts.
Topics: Caffeine; Humans; Inflammation; Obesity; Plant Extracts; Signal Transduction | 2023 |
Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO.
Topics: Adipocytes; Adolescent; Adult; Aged; Amine Oxidase (Copper-Containing); Animals; Anti-Obesity Agents | 2020 |
Nutritional management in women with polycystic ovary syndrome: A review study.
Topics: Caffeine; Fatty Acids; Female; Glycemic Index; Humans; Obesity; Polycystic Ovary Syndrome; Vitamin D | 2017 |
Coffee consumption and disease correlations.
Topics: Caffeine; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Diabetes Mellitus, Type 2; Diterpenes; | 2019 |
[Life style and male fertility].
Topics: Alcohol Drinking; Caffeine; Electromagnetic Fields; Exercise; Feeding Behavior; Hot Temperature; Hum | 2017 |
Coffee and tea: perks for health and longevity?
Topics: Antioxidants; Anxiety; Blood Glucose; Blood Pressure; Caffeine; Calcium; Cardiovascular Diseases; Co | 2013 |
Catechin- and caffeine-rich teas for control of body weight in humans.
Topics: Body Weight; Caffeine; Camellia sinensis; Catechin; Energy Metabolism; Humans; Lipid Metabolism; Obe | 2013 |
Cocoa phytochemicals: recent advances in molecular mechanisms on health.
Topics: Animals; Biological Availability; Cacao; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Flavo | 2014 |
Insufficient sleep in adolescents and young adults: an update on causes and consequences.
Topics: Accidents, Traffic; Adolescent; Caffeine; Communications Media; Depression; Humans; Obesity; Sleep; | 2014 |
Risk factors of chronic daily headache or chronic migraine.
Topics: Age Distribution; Caffeine; Central Nervous System Stimulants; Headache Disorders; Humans; Life Styl | 2015 |
Functional foods as potential therapeutic options for metabolic syndrome.
Topics: Animals; Anthocyanins; Antioxidants; Caffeine; Dietary Fiber; Disease Models, Animal; Ellagic Acid; | 2015 |
Modulation of leptin resistance by food compounds.
Topics: Agouti-Related Protein; Animals; Blood-Brain Barrier; Caffeine; Eating; Food; Hypothalamus; Leptin; | 2016 |
A Review of Natural Stimulant and Non-stimulant Thermogenic Agents.
Topics: Caffeine; Capsaicin; Central Nervous System Stimulants; Chlorogenic Acid; Ephedrine; Humans; Obesity | 2016 |
Coffee consumption, obesity and type 2 diabetes: a mini-review.
Topics: Animals; Blood Glucose; Caffeine; Chlorogenic Acid; Coffee; Diabetes Mellitus, Type 2; Disease Model | 2016 |
Nutra-ergonomics: influence of nutrition on physical employment standards and the health of workers.
Topics: Amino Acids; Beverages; Caffeine; Chronic Disease; Diet, Healthy; Dietary Proteins; Employment; Ergo | 2016 |
Sugar and Type 2 diabetes.
Topics: Beverages; Caffeine; Diabetes Mellitus, Type 2; Diet; Dietary Sugars; Energy Intake; Health Surveys; | 2016 |
The effect of caffeine on energy balance.
Topics: Animals; Anti-Obesity Agents; Appetite; Body Weight; Caffeine; Energy Intake; Energy Metabolism; Hum | 2017 |
Sugary drinks in the pathogenesis of obesity and cardiovascular diseases.
Topics: Adiposity; Animals; Beverages; Caffeine; Cardiovascular Diseases; Dietary Sucrose; Dogs; Fructose; H | 2008 |
What predicts the change from episodic to chronic migraine?
Topics: Analgesics; Caffeine; Central Nervous System Stimulants; Chronic Disease; Clinical Trials as Topic; | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
The effects of green tea on weight loss and weight maintenance: a meta-analysis.
Topics: Caffeine; Catechin; Humans; Obesity; Satiation; Tea; Weight Loss | 2009 |
Migraine chronification--concept and risk factors.
Topics: Caffeine; Disease Progression; Humans; Migraine Disorders; Obesity; Risk Factors; Sleep Apnea Syndro | 2009 |
Thermogenic ingredients and body weight regulation.
Topics: Body Weight; Caffeine; Capsaicin; Energy Metabolism; Humans; Obesity; Oxidation-Reduction; Tea; Ther | 2010 |
Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters.
Topics: Animals; Beverages; Caffeine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Food Analysis; Hum | 2010 |
[Role of environmental factors in the etiology of hepatocellular carcinoma].
Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Caffeine; Carcinoma, Hepatocellular; Coffee; Contracepti | 2010 |
Antiobesity effects of green tea catechins: a mechanistic review.
Topics: Adiposity; Animals; Anti-Obesity Agents; Appetite Depressants; Caffeine; Catechin; Drug Synergism; D | 2011 |
Beyond salt: lifestyle modifications and blood pressure.
Topics: Alcohol Drinking; Biofeedback, Psychology; Blood Pressure; Caffeine; Central Nervous System Stimulan | 2011 |
[Nutrition and miscarriages: a literature review].
Topics: Abortion, Spontaneous; Alcohol Drinking; Caffeine; Celiac Disease; Dietary Supplements; Embryo Impla | 2012 |
The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
Topics: Aminophylline; Animals; Caffeine; Ephedrine; Humans; Obesity; Plant Preparations; Theophylline; Weig | 2001 |
Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
Topics: Adrenergic beta-Agonists; Anti-Obesity Agents; Basal Metabolism; Caffeine; Citrus; Ephedra; Humans; | 2002 |
Nutrition therapy for hypertension.
Topics: Alcohol Drinking; Behavior Therapy; Caffeine; Diet; Exercise; Humans; Hypertension; Life Style; Meta | 2003 |
Metabolically active functional food ingredients for weight control.
Topics: Adipose Tissue; Animals; Body Weight; Caffeine; Calcium, Dietary; Capsaicin; Diet; Diglycerides; Eph | 2006 |
Pharmacological and surgical treatments for obesity.
Topics: Anti-Obesity Agents; Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Appetite De | 2006 |
Modifiable risk factors for impaired fertility in women: what nurse practitioners need to know.
Topics: Caffeine; Counseling; Feeding Behavior; Female; Health Behavior; Humans; Infertility, Female; Life S | 2006 |
Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea.
Topics: Animals; Body Weight; Caffeine; Capsaicin; Central Nervous System Stimulants; Energy Metabolism; Eph | 2007 |
Pharmacological rationale for the clinical use of caffeine.
Topics: Animals; Apnea; Caffeine; Central Nervous System; Headache; Humans; Hypotension; Obesity; Pain; Phos | 1995 |
[Recent progress in Holter electrocardiography, focussed on heart rate variability].
Topics: Adult; Anti-Anxiety Agents; Aprindine; Autonomic Nervous System; Benzodiazepines; Caffeine; Electroc | 1993 |
Clinical aspects of ephedrine in the treatment of obesity.
Topics: Body Composition; Caffeine; Diet, Reducing; Energy Metabolism; Ephedrine; Female; Humans; Male; Obes | 1993 |
Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
Topics: Appetite Depressants; Body Temperature Regulation; Caffeine; Ephedrine; Humans; Obesity; Sympathomim | 1995 |
[Etiological epidemiology of colorectal tumors].
Topics: Alcohol Drinking; Caffeine; Cohort Studies; Colorectal Neoplasms; Diet; Disease Susceptibility; Etha | 1996 |
Food intake, energy balance and body weight control.
Topics: Alcohol Drinking; Animals; Caffeine; Capsaicin; Diet; Eating; Energy Intake; Energy Metabolism; Huma | 1997 |
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobu | 1998 |
What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Topics: Adrenergic beta-Agonists; Animals; Appetite Depressants; Caffeine; Central Nervous System Stimulants | 1998 |
Drug treatment of obesity.
Topics: Androgen Antagonists; Androgens; Anti-Obesity Agents; Appetite Depressants; Caffeine; Central Nervou | 1999 |
Thermogenic drugs as a strategy for treatment of obesity.
Topics: Adrenal Glands; Anti-Obesity Agents; Caffeine; Cyclobutanes; Energy Metabolism; Ephedrine; Humans; L | 2000 |
Herbal simulation of ephedrine and caffeine in treatment of obesity.
Topics: Appetite Depressants; Caffeine; Drug Therapy, Combination; Ephedrine; Humans; Obesity; Plant Prepara | 2002 |
Pharmacology of thermogenic drugs.
Topics: Adrenergic beta-Agonists; Body Temperature Regulation; Caffeine; Drug Therapy, Combination; Ephedrin | 1992 |
Nonpharmacological approaches to the control of high blood pressure. Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.
Topics: Alcohol Drinking; Animals; Biofeedback, Psychology; Blood Pressure; Body Weight; Caffeine; Calcium, | 1986 |
Standardization of lipid, lipoprotein, and apolipoprotein measurements.
Topics: Apolipoproteins; Caffeine; Diet; Female; Humans; Lipids; Lipoproteins; Male; Obesity; Physical Exert | 1988 |
[Risks in the development of hypertension].
Topics: Alcohol Drinking; Blood Pressure; Caffeine; Contraceptives, Oral; Diet; Female; Humans; Hypertension | 1988 |
Energy utilization in human obesity.
Topics: Basal Metabolism; Body Temperature Regulation; Caffeine; Cold Temperature; Eating; Energy Metabolism | 1987 |
Risks for arterial hypertension.
Topics: Adult; Age Factors; Alcohol Drinking; Black People; Blood Pressure; Caffeine; Contraceptives, Oral; | 1986 |
Insulin receptor- and nonreceptor-controlled cellular substrate processing. A review of clinical studies in the isolated human adipocyte model.
Topics: 3-O-Methylglucose; Adipose Tissue; Biological Transport; Blood Cells; Caffeine; Cells, Cultured; Dia | 1985 |
Dietary factors and hypertension.
Topics: Caffeine; Calcium; Coffee; Diet; Dietary Fats; Ethanol; Humans; Hypertension; Obesity; Potassium; So | 1985 |
[Epidemiology of hypertension].
Topics: Adult; Age Factors; Alcohol Drinking; Blood Pressure; Caffeine; Cerebrovascular Disorders; Coronary | 1973 |
Trials
58 trials available for caffeine and Obesity
| Article | Year |
|---|---|
Acute effect of coffee on arterial stiffness and endothelial function in overweight and obese individuals: A randomized clinical trial.
Topics: Caffeine; Coffee; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Obesity; Overwei | 2022 |
Caffeine Optimizes HIIT Benefits on Obesity-associated Metabolic Adversity in Women.
Topics: Adolescent; Adult; Blood Glucose; Body Fat Distribution; Caffeine; Cardiorespiratory Fitness; Endoto | 2020 |
Effects of a topical lotion containing aminophylline, caffeine, yohimbe, l-carnitine, and gotu kola on thigh circumference, skinfold thickness, and fat mass in sedentary females.
Topics: Adiposity; Administration, Cutaneous; Adolescent; Adult; Aminophylline; Caffeine; Carnitine; Centell | 2019 |
Gender and body mass index modify the effect of increasing amounts of caffeinated coffee on postprandial glucose and insulin concentrations; a randomized, controlled, clinical trial.
Topics: Adult; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; Caffeine; Central Nervous Syste | 2013 |
Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals.
Topics: Adult; Appetite; Body Mass Index; Body Weight; Breakfast; Caffeine; Coffee; Cross-Over Studies; Ener | 2013 |
The effect of leptin, caffeine/ephedrine, and their combination upon visceral fat mass and weight loss.
Topics: Absorptiometry, Photon; Adolescent; Adult; Body Composition; Body Weight; Caffeine; Double-Blind Met | 2013 |
Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study.
Topics: Blood Pressure; Body Mass Index; Body Weight Maintenance; Bread; Caffeine; Camellia sinensis; Catech | 2015 |
Caffeine increases sugar-sweetened beverage consumption in a free-living population: a randomised controlled trial.
Topics: Adolescent; Adult; Caffeine; Carbonated Beverages; Central Nervous System Stimulants; Diet Records; | 2015 |
The effect of caffeine and albuterol on body composition and metabolic rate.
Topics: Adolescent; Adult; Albuterol; Animals; Body Composition; Caffeine; Cross-Over Studies; Double-Blind | 2015 |
Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women.
Topics: Adiponectin; Administration, Oral; Aged; Blood Glucose; Body Mass Index; Body Weight; Caffeine; Cate | 2016 |
Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.
Topics: Adipose Tissue; Adiposity; Body Composition; Body Mass Index; Bone and Bones; Bone Density; Caffeine | 2016 |
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response | 2016 |
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response | 2016 |
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response | 2016 |
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response | 2016 |
Green tea, weight loss and physical activity.
Topics: Aged; Blood Glucose; Body Mass Index; Caffeine; Catechin; Exercise; Female; Humans; Israel; Male; Ob | 2017 |
Dairy calcium supplementation in overweight or obese persons: its effect on markers of fat metabolism.
Topics: Adipose Tissue; Adult; Basal Metabolism; Biomarkers; Caffeine; Calcium; Calcium, Dietary; Cross-Over | 2008 |
The beta-adrenergic antagonist propranolol partly abolishes thermogenic response to bioactive food ingredients.
Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Blood Pressure; Caffeine; Capsaicin; Catechin; | 2009 |
Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study.
Topics: Adipose Tissue; Analysis of Variance; Anti-Obesity Agents; Area Under Curve; Biomarkers; Caffeine; C | 2009 |
Epigallocatechin-3-gallate and postprandial fat oxidation in overweight/obese male volunteers: a pilot study.
Topics: Adult; Antioxidants; Caffeine; Catechin; Cross-Over Studies; Dietary Supplements; Dose-Response Rela | 2010 |
Physiological effects of caffeine, epigallocatechin-3-gallate, and exercise in overweight and obese women.
Topics: Adolescent; Adult; Antioxidants; Body Composition; Caffeine; Cardiovascular Physiological Phenomena; | 2010 |
Evaluation of the efficacy of a topical cosmetic slimming product combining tetrahydroxypropyl ethylenediamine, caffeine, carnitine, forskolin and retinol, In vitro, ex vivo and in vivo studies.
Topics: Adipose Tissue; Administration, Cutaneous; Adult; Caffeine; Carnitine; Colforsin; Cosmetics; Dermis; | 2011 |
The influence of caffeine on energy content of sugar-sweetened beverages: 'the caffeine-calorie effect'.
Topics: Adolescent; Adult; Beverages; Caffeine; Child; Child, Preschool; Dietary Sucrose; Energy Intake; Fem | 2011 |
Effects of green tea extracts on non-shivering thermogenesis during mild cold exposure in young men.
Topics: Adult; Area Under Curve; Caffeine; Camellia sinensis; Catechin; Cold Temperature; Diabetes Mellitus; | 2013 |
An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
Topics: Adult; Anti-Obesity Agents; Blood Pressure; Body Mass Index; Caffeine; Cardiovascular Diseases; Doub | 2002 |
Effects of green tea on weight maintenance after body-weight loss.
Topics: Adolescent; Adult; Body Composition; Body Mass Index; Body Weight; Caffeine; Energy Metabolism; Fema | 2004 |
Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss.
Topics: Administration, Oral; Adult; Area Under Curve; Blood Glucose; C-Peptide; Caffeine; Central Nervous S | 2004 |
Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
Topics: Adolescent; Adult; Aged; Basal Metabolism; Body Composition; Caffeine; Diet; Double-Blind Method; Ep | 2004 |
A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
Topics: Adult; Anti-Obesity Agents; Benzyl Alcohols; Body Mass Index; Caffeine; Cola; Double-Blind Method; D | 2004 |
Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes.
Topics: Adult; Area Under Curve; Blood Glucose; Caffeine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Doub | 2004 |
Is an ephedrine caffeine treatment contraindicated in hypertension?
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Appetite Depressants; Ca | 1997 |
Bioactive food stimulants of sympathetic activity: effect on 24-h energy expenditure and fat oxidation.
Topics: Adult; Caffeine; Calcium, Dietary; Calorimetry, Indirect; Capsaicin; Catechin; Central Nervous Syste | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation.
Topics: Adipose Tissue; Adolescent; Adult; Basal Metabolism; Caffeine; Diet, Reducing; Double-Blind Method; | 2005 |
Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Apolipoproteins; Caffeine; Cholesterol; Cholesterol, HD | 2006 |
Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
Topics: Adult; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Body Weight; Caffeine; Diet | 2006 |
Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Topics: Adipose Tissue; Anti-Obesity Agents; Body Composition; Body Weight; Caffeine; Calcium, Dietary; Came | 2007 |
Are energy drinks contributing to the obesity epidemic?
Topics: Adolescent; Adult; Beverages; Caffeine; Carbon Dioxide; Cross-Over Studies; Dietary Sucrose; Energy | 2006 |
Evaluation of the effects of caffeine in the microcirculation and edema on thighs and buttocks using the orthogonal polarization spectral imaging and clinical parameters.
Topics: Adipose Tissue; Administration, Topical; Adult; Alcohol Drinking; Buttocks; Caffeine; Edema; Exercis | 2007 |
Three controlled trials of weight loss with phenylpropanolamine.
Topics: Adolescent; Adult; Appetite Depressants; Blood Pressure; Body Weight; Caffeine; Clinical Trials as T | 1982 |
[Effect of caffeine on the physical achievement of obese children].
Topics: Adolescent; Caffeine; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Energy Meta | 1982 |
Ephedrine as an anorectic: the story of the 'Elsinore pill'.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Diet, Reducing; Diethylpropion; Drug Combinations | 1981 |
Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals.
Topics: Adult; Basal Metabolism; Caffeine; Carbohydrate Metabolism; Coffee; Diet; Energy Metabolism; Humans; | 1980 |
Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals.
Topics: Adult; Basal Metabolism; Caffeine; Carbohydrate Metabolism; Coffee; Diet; Energy Metabolism; Humans; | 1980 |
Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals.
Topics: Adult; Basal Metabolism; Caffeine; Carbohydrate Metabolism; Coffee; Diet; Energy Metabolism; Humans; | 1980 |
Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals.
Topics: Adult; Basal Metabolism; Caffeine; Carbohydrate Metabolism; Coffee; Diet; Energy Metabolism; Humans; | 1980 |
Caffeine pharmacokinetics in obesity and following significant weight reduction.
Topics: Administration, Oral; Adolescent; Adult; Antipyrine; Body Mass Index; Caffeine; Female; Humans; Male | 1995 |
The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Topics: Body Composition; Caffeine; Cholesterol; Cholesterol, HDL; Diet, Reducing; Double-Blind Method; Ephe | 1994 |
The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Topics: Adult; Blood Glucose; Caffeine; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; E | 1993 |
Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Topics: Adolescent; Adult; Aged; Blood Pressure; Body Mass Index; Caffeine; Double-Blind Method; Ephedrine; | 1994 |
Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Topics: Adult; Blood Pressure; Caffeine; Double-Blind Method; Drug Therapy, Combination; Ephedrine; Female; | 1993 |
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Energy Intake; Ephedrine; Female; Humans; Male; | 1993 |
Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
Topics: Appetite Depressants; Body Temperature Regulation; Caffeine; Ephedrine; Humans; Obesity; Sympathomim | 1995 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans.
Topics: Adipose Tissue; Adult; Caffeine; Catechin; Central Nervous System Stimulants; Circadian Rhythm; Ener | 1999 |
Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Topics: Adipose Tissue; Adolescent; Apolipoproteins B; Blood Pressure; Body Composition; Caffeine; Double-Bl | 2000 |
The effect of an herbal dietary supplement containing ephedrine and caffeine on oxygen consumption in humans.
Topics: Caffeine; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Ephedrine; Female; Humans; O | 2000 |
An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
Topics: Adult; Anthropometry; Blood Pressure; Caffeine; Dietary Supplements; Double-Blind Method; Drug Combi | 2001 |
Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients.
Topics: Caffeine; Double-Blind Method; Female; Gastric Emptying; Humans; Ilex paraguariensis; Male; Obesity; | 2001 |
A double blind clinical evaluation of a phenylpropanolamine-caffeine-vitamine combination and a placebo in the treatment of exogenous obesity.
Topics: Adolescent; Adult; Aged; Caffeine; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male | 1975 |
The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Topics: Administration, Oral; Adult; Analysis of Variance; Blood Pressure; Caffeine; Chemotherapy, Adjuvant; | 1992 |
The effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women.
Topics: Body Composition; Caffeine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Energy M | 1992 |
Ephedrine, caffeine and aspirin promote weight loss in obese subjects.
Topics: Adult; Aspirin; Caffeine; Drug Therapy, Combination; Ephedrine; Female; Humans; Male; Obesity; Weigh | 1990 |
A controlled trial using ephedrine in the treatment of obesity.
Topics: Caffeine; Clinical Trials as Topic; Drug Combinations; Ephedrine; Humans; Obesity; Theophylline | 1986 |
The thermogenic properties of ephedrine/methylxanthine mixtures: human studies.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Calorimetry; Disease Susceptibility; | 1986 |
The effects of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers.
Topics: Adult; Body Weight; Caffeine; Half-Life; Humans; Kinetics; Male; Obesity; Physical Exertion | 1987 |
Other Studies
126 other studies available for caffeine and Obesity
| Article | Year |
|---|---|
Caffeine intake reduces sedentary time and increases physical activity predisposition in obese police officers.
Topics: Caffeine; Eating; Exercise; Humans; Obesity; Police; Sedentary Behavior | 2021 |
Associations of Blood Caffeine and Genetically Predicted Coffee Consumption with Anthropometric Measures of Obesity: A Two Sample Mendelian Randomization Study.
Topics: Caffeine; Coffee; Genome-Wide Association Study; Humans; Mendelian Randomization Analysis; Obesity; | 2022 |
Association of caffeine and caffeine metabolites with obesity among children and adolescents: National Health and Nutrition Examination Survey (NHANES) 2009-2014.
Topics: Adiposity; Adolescent; Body Mass Index; Caffeine; Child; Cross-Sectional Studies; Female; Humans; Ma | 2022 |
Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model.
Topics: Animals; Caffeine; Dogs; Harmine; Male; Metabolic Diseases; Metabolome; Obesity; Theophylline | 2022 |
Effects of Isoprenaline on ventricular myocyte shortening and Ca
Topics: Animals; Caffeine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Isoproterenol; Myocytes, Cardiac; O | 2022 |
Association of Maternal Caffeine Consumption During Pregnancy With Child Growth.
Topics: Body Mass Index; Caffeine; Child; Child, Preschool; Cohort Studies; Female; Humans; Male; Obesity; P | 2022 |
The synergistic effect of sea cucumber saponins and caffeine on preventing obesity in high-fat diet-fed mice by extending the action duration of caffeine.
Topics: Animals; Caffeine; Cytochrome P-450 CYP1A2; Diet, High-Fat; Mice; Mice, Obese; Obesity; Saponins; Se | 2023 |
Improvement of obesity by Liupao tea is through the IRS-1/PI3K/AKT/GLUT4 signaling pathway according to network pharmacology and experimental verification.
Topics: 3T3-L1 Cells; Animals; Caffeine; CCAAT-Enhancer-Binding Protein-alpha; Humans; Insulin; Insulin Rece | 2023 |
Preventive effect of Ya'an Tibetan tea on obesity in rats fed with a hypercaloric high-fat diet revealed by gut microbiology and metabolomics studies.
Topics: Animals; Caffeine; Diet, High-Fat; Obesity; Rats; RNA, Ribosomal, 16S; Tea; Tibet | 2023 |
Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat.
Topics: Adipose Tissue; Caffeine; Coffee; Female; Humans; Male; Metabolic Syndrome; Obesity; Prospective Stu | 2023 |
Inversely Regulated Inflammation-Related Processes Mediate Anxiety-Obesity Links in Zebrafish Larvae and Adults.
Topics: Animals; Anxiety; Caffeine; Inflammation; Larva; Obesity; Zebrafish | 2023 |
Anti-obesity effects of chlorogenic acid and caffeine- lipid nanoparticles through PPAR-γ/C/EBP-ɑ pathways.
Topics: Caffeine; Chlorogenic Acid; Coffee; Drug Carriers; Humans; Nanoparticles; Obesity; PPAR alpha | 2023 |
Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans.
Topics: Animals; Caffeine; Endocannabinoids; Humans; Kidney; Male; Obesity; Renal Insufficiency, Chronic | 2023 |
Dietary caffeine intake is associated with favorable metabolic profile among apparently healthy overweight and obese individuals.
Topics: Body Mass Index; Caffeine; Cross-Sectional Studies; Eating; Humans; Insulin; Insulin Resistance; Obe | 2023 |
Collaborative effects of chlorogenic acid and caffeine on lipid metabolism via the AMPKα-LXRα/SREBP-1c pathway in high-fat diet-induced obese mice.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Body Weight; Caffeine; Chlorogenic Acid; Die | 2019 |
KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Body Weight; Caffeine; Capilla | 2020 |
Astilbin lowers the effective caffeine dose for decreasing lipid accumulation via activating AMPK in high-fat diet-induced obese mice.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Obesity Agents; Caffeine; Diet, High-Fat; Dietary Suppl | 2021 |
Fubrick tea attenuates high-fat diet induced fat deposition and metabolic disorder by regulating gut microbiota and caffeine metabolism.
Topics: Animals; Anti-Obesity Agents; Caffeine; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; | 2020 |
Beyond taste and easy access: Physical, cognitive, interpersonal, and emotional reasons for sugary drink consumption among children and adolescents.
Topics: Adolescent; Beverages; Caffeine; Carbonated Beverages; Child; Cognition; Humans; Obesity; Taste | 2020 |
Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism.
Topics: Animals; Anti-Obesity Agents; Bile Acids and Salts; Caffeine; Catechin; Cholesterol 7-alpha-Hydroxyl | 2021 |
Do sleep quality and caffeine consumption mediate the relationship between late chronotype and body mass index?
Topics: Adult; Beverages; Body Mass Index; Caffeine; Circadian Rhythm; Exercise; Female; Humans; Male; Obesi | 2021 |
Anti-obesity effect of a novel caffeine-loaded dissolving microneedle patch in high-fat diet-induced obese C57BL/6J mice.
Topics: Administration, Cutaneous; Animals; Anti-Obesity Agents; Caffeine; Cell Survival; Cholesterol; Diet, | 2017 |
Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes.
Topics: 3T3 Cells; Adipocytes; Adult; Animals; Biological Transport; Caffeine; Cell Differentiation; Female; | 2017 |
Caffeine inhibits hypothalamic A
Topics: Animals; Caffeine; Diet, High-Fat; Energy Metabolism; Glucose; Humans; Hypothalamus; Leptin; Male; M | 2017 |
Redox status on different regions of the central nervous system of obese and lean rats treated with green tea extract.
Topics: Animals; Antioxidants; Caffeine; Catalase; Central Nervous System; Cytokines; Diet; Flavonoids; Gluc | 2019 |
Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats.
Topics: Adiposity; Animals; Caffeine; Cells, Cultured; Diet, High-Fat; Fatty Liver; Immune System Diseases; | 2018 |
Decaffeinated green coffee bean extract and the components of the metabolic syndrome.
Topics: Beverages; Body Mass Index; Body Weight; Caffeine; Coffee; Cross-Over Studies; Cross-Sectional Studi | 2018 |
Ban on sale of energy drinks to children.
Topics: Adolescent; Caffeine; Child; Child, Preschool; Commerce; Direct-to-Consumer Advertising; Energy Drin | 2018 |
Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndrome.
Topics: Animals; Caffeine; Chlorogenic Acid; Coffee; Disease Models, Animal; Dysbiosis; Fatty Acids, Volatil | 2018 |
Availability and composition of weight-loss supplements in Sri Lanka.
Topics: Anti-Obesity Agents; Caffeine; Dietary Supplements; Garcinia; Humans; Obesity; Plants; Sri Lanka; Te | 2020 |
Coadministration of epigallocatechin-3-gallate (EGCG) and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.
Topics: Animals; Body Weight; Caffeine; Catechin; Diet, High-Fat; Dose-Response Relationship, Drug; Drug The | 2019 |
Maternal, but not paternal or grandparental, caffeine intake is associated with childhood obesity and adiposity: The Lifeways Cross-Generation Cohort Study.
Topics: Adiposity; Adult; Body Mass Index; Caffeine; Child; Child, Preschool; Coffee; Female; Humans; Male; | 2019 |
Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer.
Topics: Aged; Aged, 80 and over; Body Mass Index; Caffeine; Coffee; Eating; Endometrial Neoplasms; Female; F | 2013 |
Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Topics: Adult; Alcohol Drinking; beta-Crystallin B Chain; Biomarkers, Tumor; Black or African American; Brea | 2014 |
Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics.
Topics: Animals; Blood Glucose; Body Composition; Caffeine; Coffee; Diet, High-Fat; Gastrointestinal Tract; | 2014 |
Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase.
Topics: Adiponectin; Adipose Tissue, White; Adiposity; AMP-Activated Protein Kinases; Animals; Body Weight; | 2014 |
Night shift work at specific age ranges and chronic disease risk factors.
Topics: Adult; Age Factors; Body Mass Index; Caffeine; Cardiovascular Diseases; Chronic Disease; Energy Inta | 2015 |
A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice.
Topics: Adipogenesis; Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeine; Diet, High-Fat; F | 2015 |
The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Caffei | 2015 |
Maternal serum paraxanthine during pregnancy and offspring body mass index at ages 4 and 7 years.
Topics: Adult; Biomarkers; Body Mass Index; Caffeine; Case-Control Studies; Child; Child, Preschool; Female; | 2015 |
Urine and serum metabolite profiling of rats fed a high-fat diet and the anti-obesity effects of caffeine consumption.
Topics: Animals; Caffeine; Cholesterol; Dietary Fats; Fatty Acids; Gas Chromatography-Mass Spectrometry; Obe | 2015 |
Role of Caffeine Intake on Erectile Dysfunction in US Men: Results from NHANES 2001-2004.
Topics: Adult; Caffeine; Comorbidity; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Nutriti | 2014 |
Green tea extract activates AMPK and ameliorates white adipose tissue metabolic dysfunction induced by obesity.
Topics: Adipose Tissue, White; Alanine Transaminase; AMP-Activated Protein Kinases; Animals; Antioxidants; A | 2016 |
Associations between night work and BMI, alcohol, smoking, caffeine and exercise--a cross-sectional study.
Topics: Adult; Alcohol Drinking; Body Mass Index; Caffeine; Cardiovascular Diseases; Cross-Sectional Studies | 2015 |
The effects of BADGE and caffeine on the time-course response of adiponectin and lipid oxidative enzymes in high fat diet-fed C57BL/6J mice: correlation with reduced adiposity and steatosis.
Topics: Acetyl-CoA Carboxylase; Adiponectin; Animals; Biphenyl Compounds; Caffeine; Carnitine O-Palmitoyltra | 2008 |
Treatment of hypothalamic obesity with caffeine and ephedrine.
Topics: Adolescent; Adult; Anti-Obesity Agents; Caffeine; Ephedrine; Female; Humans; Hypothalamic Diseases; | 2008 |
Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity.
Topics: Adult; Algorithms; Anthropometry; Caffeine; Cluster Analysis; Diet; Energy Intake; Ephedra; Female; | 2009 |
Weight and plasma lipid control by decaffeinated green tea.
Topics: Adiponectin; Animals; Anti-Obesity Agents; Caffeine; Catechin; Cholesterol; Feces; Hyperlipidemias; | 2009 |
Green tea catechins, caffeine and body-weight regulation.
Topics: Adolescent; Adult; Animals; Body Weight; Caffeine; Catechin; Catechol O-Methyltransferase; Dose-Resp | 2010 |
Body weight gain in rats consuming sweetened liquids. Effects of caffeine and diet composition.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Diet, Fat-Restricted; Dietary Fats; Dietary Su | 2010 |
Altered xanthine oxidase and N-acetyltransferase activity in obese children.
Topics: Arylamine N-Acetyltransferase; Biomarkers; Body Weight; Caffeine; Case-Control Studies; Child; Cytoc | 2011 |
Impaired sympathoadrenal axis function contributes to enhanced insulin secretion in prediabetic obese rats.
Topics: Adrenal Medulla; Animals; Blood Glucose; Caffeine; Carbachol; Catecholamines; Glucose Tolerance Test | 2011 |
Caffeine and screen time in adolescence: associations with short sleep and obesity.
Topics: Adolescent; Age Distribution; Analysis of Variance; Anthropometry; Arizona; Body Mass Index; Caffein | 2011 |
Preventing childhood obesity: wake up, it's time for sleep!
Topics: Body Mass Index; Caffeine; Female; Humans; Male; Obesity; Sleep Wake Disorders; Television | 2011 |
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Topics: Adolescent; Adult; Aged; Benzodiazepines; Body Weights and Measures; Caffeine; Chlorzoxazone; Comput | 2011 |
Intake of cola beverages containing caffeine does not increase, but reduces body weight.
Topics: Caffeine; Dietary Sucrose; Energy Intake; Female; Humans; Male; Obesity; Sucrose; Taste; Weight Gain | 2012 |
Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid.
Topics: Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeine; Corn Oil; Diet, High-Fat; Dose- | 2012 |
Caffeine attenuates metabolic syndrome in diet-induced obese rats.
Topics: Adipose Tissue; Animals; Blood Pressure; Caffeine; Cardiovascular System; Diet, High-Fat; Dietary Ca | 2012 |
Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard.
Topics: Caffeine; Electrocardiography; Female; Humans; Injections, Intradermal; Mesotherapy; Middle Aged; Ob | 2012 |
What is green coffee extract?
Topics: Anti-Obesity Agents; Caffeine; Chlorogenic Acid; Coffee; Consumer Product Safety; Dietary Supplement | 2013 |
[Ephedrine and ephedra in weight loss products and other preparations].
Topics: Adverse Drug Reaction Reporting Systems; Appetite Depressants; Arrhythmias, Cardiac; Caffeine; Centr | 2002 |
[Letigen, insulin resistance and treatment of obesity].
Topics: Appetite Depressants; Caffeine; Ephedrine; Humans; Insulin Resistance; Obesity | 2002 |
Nutrition, physical activity, and obesity.
Topics: Caffeine; Carbonated Beverages; Central Nervous System Stimulants; Child; Child Nutritional Physiolo | 2002 |
[Liberalized use of Letigen--how is the documentation?].
Topics: Adult; Appetite Depressants; Body Mass Index; Caffeine; Central Nervous System Stimulants; Child; Dr | 2002 |
[Letigen, insulin resistance and treatment of obesity--again].
Topics: Appetite Depressants; Caffeine; Central Nervous System Stimulants; Ephedrine; Humans; Insulin Resist | 2002 |
[Obesity epidemic after Letigen].
Topics: Appetite Depressants; Caffeine; Central Nervous System Stimulants; Denmark; Diabetes Mellitus, Type | 2002 |
Induction of the procarcinogen-activating CYP1A2 by a herbal dietary supplement in rats and humans.
Topics: Animals; Blotting, Western; Caffeine; Carcinogens; Cytochrome P-450 CYP1A2; Dietary Supplements; Dos | 2003 |
EXTREME SENSITIVITY OF OBESE HYPERGLYCEMIC MICE TO CAFFEINE AND COFFEE.
Topics: Alloxan; Animals; Blood Glucose; Caffeine; Coffee; Glucose Tolerance Test; Hyperglycemia; Insulin; M | 1964 |
[Effects of long-term administration of caffeine on fat storage in ovariectomized rats].
Topics: Adipose Tissue; Animals; Body Weight; Bone and Bones; Bone Density; Caffeine; Calcium; Eating; Femal | 2004 |
Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States.
Topics: Alanine Transaminase; Alcohol Drinking; Caffeine; Coffee; Female; Glucose Metabolism Disorders; Hepa | 2005 |
Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training.
Topics: Adipose Tissue; Administration, Oral; Blood Glucose; Caffeine; Diabetes Mellitus, Type 2; Energy Int | 2005 |
Effect of caffeine on the body fat and lipid metabolism of rats fed on a high-fat diet.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Caffeine; Catecholamines; Dietary Fats; Dose | 2005 |
Changes in caffeine intake and long-term weight change in men and women.
Topics: Adult; Age Factors; Body Mass Index; Caffeine; Central Nervous System Stimulants; Coffee; Confidence | 2006 |
Dietary factors related to higher plasma fibrinogen levels of Japanese-americans in hawaii compared with Japanese in Japan.
Topics: Adult; Asian; Asian People; Caffeine; Carbohydrates; Diet; Female; Fibrinogen; Hawaii; Humans; Iron; | 2006 |
Health behaviors in breast cancer survivors experiencing bone loss.
Topics: Absorptiometry, Photon; Adult; Aged; Alcohol Drinking; Attitude to Health; Breast Neoplasms; Caffein | 2006 |
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community.
Topics: Aged; Caffeine; Carbonated Beverages; Cholesterol, LDL; Cohort Studies; Cross-Sectional Studies; Dia | 2007 |
Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats.
Topics: Animals; Body Weight; Caffeine; Collagen Type IV; Cyclic N-Oxides; Diabetic Nephropathies; Hemodynam | 2007 |
Features associated with diet pill use in individuals with eating disorders.
Topics: Adult; Alcohol Drinking; Anti-Obesity Agents; Body Mass Index; Caffeine; Cathartics; Emetics; Europe | 2008 |
Nonprescription appetite suppressants.
Topics: Appetite Depressants; Caffeine; Humans; Nonprescription Drugs; Obesity; Phenylpropanolamine | 1983 |
Effects of sucrose, caffeine, and cola beverages on obesity, cold resistance, and adipose tissue cellularity.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Beverages; Body Temperature Regulation; Body Weight; | 1983 |
Precursors of hypertension: a review.
Topics: Blood Pressure; Caffeine; Ethnicity; Female; Humans; Hypertension; Obesity; Pulse; Racial Groups; Sm | 1983 |
Caffeine: its effect on catecholamines and metabolism in lean and obese humans.
Topics: Adult; Blood Glucose; Body Temperature Regulation; Caffeine; Catecholamines; Fatty Acids, Nonesterif | 1981 |
The effect of caffeine and physical exercise on blood lactate levels of obese children.
Topics: Adolescent; Caffeine; Child; Fatty Acids, Nonesterified; Humans; Lactates; Lactic Acid; Muscles; Obe | 1982 |
Dietary considerations in hypertension.
Topics: Alcohol Drinking; Caffeine; Coronary Disease; Diastole; Diet, Sodium-Restricted; Dietary Fats; Femal | 1981 |
[Obesity, disorder in the regulation of energy balance].
Topics: Caffeine; Cold Temperature; Energy Metabolism; Female; Glucose; Humans; Male; Obesity; Physical Exer | 1980 |
[Does post-caffeine increase in thermogenesis facilitate the treatment of obesity?].
Topics: Adipose Tissue; Adult; Body Temperature; Caffeine; Coffee; Female; Humans; Middle Aged; Obesity | 1980 |
Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Catecholamines; Cytochrome P-450 CYP | 1995 |
Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Catecholamines; Cytochrome P-450 CYP | 1995 |
Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Catecholamines; Cytochrome P-450 CYP | 1995 |
Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Catecholamines; Cytochrome P-450 CYP | 1995 |
Effect of caffeine on the levels of brain serotonin and catecholamine in the genetically obese mice.
Topics: Adipose Tissue; Animals; Brain; Caffeine; Catecholamines; Female; Male; Mice; Mice, Obese; Obesity; | 1994 |
Relationship between basal metabolic rate, thermogenic response to caffeine, and body weight loss following combined low calorie and exercise treatment in obese women.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Diet, Reducing; Energy Intake; Exerc | 1994 |
Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.
Topics: Adult; Aspirin; Basal Metabolism; Body Constitution; Body Mass Index; Body Temperature Regulation; C | 1996 |
Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.
Topics: Adrenergic alpha-Antagonists; Adult; Appetite Depressants; Body Mass Index; Caffeine; Cardiography, | 1998 |
Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine.
Topics: Animals; Blood Glucose; Body Composition; Caffeine; Eating; Energy Metabolism; Ephedrine; Glucose To | 1998 |
Anti-obesity action of oolong tea.
Topics: Adipocytes; Animals; Caffeine; Cell-Free System; Dietary Fats; Eating; Female; Lipase; Lipolysis; Li | 1999 |
Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats.
Topics: Animals; Caffeine; Calcium; Calcium-Transporting ATPases; Cardiovascular Diseases; Diabetes Mellitus | 1999 |
Adrenomedullary response to caffeine in prepubertal and pubertal obese subjects.
Topics: Adolescent; Adrenal Medulla; Caffeine; Central Nervous System Stimulants; Child; Epinephrine; Estrad | 1999 |
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug | 1999 |
Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Caffeine; Catechin; Central Nervous Sys | 2000 |
Renal and metabolic effects of caffeine in obese (fa/fa(cp)), diabetic, hypertensive ZSF1 rats.
Topics: Animals; Caffeine; Diabetes Mellitus, Experimental; Hypertension; Kidney; Male; Obesity; Rats | 2001 |
Hot foods--unexpected help with energy balance?
Topics: Caffeine; Capsaicin; Diet; Energy Intake; Energy Metabolism; Food; Humans; Micronutrients; Obesity; | 2001 |
Pancreatic beta-cells from obese-hyperglycemic mice are characterized by excessive firing of cytoplasmic Ca2+ transients.
Topics: Animals; Caffeine; Calcium; Cytoplasm; Glucagon; Hyperglycemia; Islets of Langerhans; Leptin; Mice; | 2001 |
Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol.
Topics: Adult; Alcohol Drinking; Caffeine; Central Nervous System Stimulants; Drug Interactions; Ephedrine; | 2001 |
Recent developments concerning diet and hypertension.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Caffeine; Coffee; Diet; Dietary Fiber; Dietary P | 2001 |
Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats.
Topics: Animals; Caffeine; Diabetes Mellitus; Diabetic Nephropathies; Drug Administration Schedule; Glomerul | 2002 |
The volitional disorders.
Topics: Alcoholism; Caffeine; Central Nervous System Stimulants; Dietary Carbohydrates; Disease; Hallucinoge | 1976 |
The volitional disorders.
Topics: Alcoholism; Caffeine; Carbohydrates; Central Nervous System Stimulants; Feeding and Eating Disorders | 1978 |
[Lipid mobilization in obesity without carbohydrate intolerance. 2. Caffeine-stimulated lipolysis].
Topics: Adult; Blood Glucose; Caffeine; Fatty Acids, Nonesterified; Female; Glycerol; Humans; Insulin; Lipid | 1976 |
Changes in plasma cortisol, glucose and free fatty acids after caffeine ingestion in obese women.
Topics: Adult; Blood Glucose; Caffeine; Central Nervous System; Fatty Acids, Nonesterified; Female; Humans; | 1975 |
Potentiation of the thermogenic antiobesity effects of ephedrine by dietary methylxanthines: adenosine antagonism or phosphodiesterase inhibition?
Topics: Adenosine; Adipose Tissue, Brown; Animals; Caffeine; Diet; Dose-Response Relationship, Drug; Drug Sy | 1992 |
Reduced adipsin expression in murine obesity: effect of age and treatment with the sympathomimetic-thermogenic drug mixture ephedrine and caffeine.
Topics: Adipose Tissue, Brown; Aging; Animals; Body Temperature; Caffeine; Complement Factor D; Drug Combina | 1990 |
Caffeine and ephedrine stimulated thermogenesis in LA-corpulent rats.
Topics: Adipose Tissue, Brown; Animals; Body Temperature Regulation; Caffeine; Ephedrine; Female; Obesity; R | 1986 |
Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers.
Topics: Adult; Basal Metabolism; Body Temperature Regulation; Caffeine; Energy Intake; Energy Metabolism; Fe | 1989 |
Cigarette smoking and other correlates of cytologic estrogen effect in postmenopausal women.
Topics: Aged; Caffeine; Estrogens; Female; Humans; Menopause; Middle Aged; Obesity; Risk Factors; Smoking; V | 1988 |
Reversal of obesity in the genetically obese fa/fa Zucker rat with an ephedrine/methylxanthines thermogenic mixture.
Topics: Animals; Body Temperature Regulation; Body Weight; Caffeine; Drug Therapy, Combination; Eating; Ener | 1987 |
[Hypertension, obesity, alcohol, tobacco and caffeine consumption before vascular diseases, in the statutory community of Navarra].
Topics: Adult; Aged; Alcohol Drinking; Caffeine; Cardiovascular Diseases; Female; Humans; Hypertension; Male | 1987 |
Risk factors for myocardial infarction in young women.
Topics: Adult; Caffeine; Contraceptives, Oral; Diabetes Complications; Epidemiologic Methods; Family; Female | 1987 |
A case-control study of factors affecting the development of renal cell cancer.
Topics: Adult; Aged; Alcohol Drinking; Caffeine; Epidemiologic Methods; Female; Humans; Kidney Neoplasms; Ma | 1986 |
Prevention of genetic fa/fa obesity with an ephedrine-methylxanthines thermogenic mixture.
Topics: Animals; Body Composition; Body Temperature Regulation; Caffeine; Energy Intake; Energy Metabolism; | 1987 |
The thermogenic properties of ephedrine/methylxanthine mixtures: animal studies.
Topics: Administration, Oral; Animals; Body Composition; Body Weight; Caffeine; Drug Combinations; Energy Me | 1986 |
Caffeine disposition in obesity.
Topics: Adult; Body Weight; Caffeine; Female; Humans; Kinetics; Male; Obesity | 1985 |
Nutritional and lifestyle approaches to the prevention and management of hypertension.
Topics: Alcohol Drinking; Blood Pressure; Caffeine; Calcium, Dietary; Diet; Diet, Sodium-Restricted; Dietary | 1985 |
Nutritional influences on the fibrinolytic system.
Topics: Alcoholic Beverages; Allium; Ascorbic Acid; Caffeine; Capsicum; Diet; Dietary Fats; Fibrinolysis; Ga | 1985 |
Fatty acid mobilization in obese mice.
Topics: Adenine Nucleotides; Adenylyl Cyclases; Adipose Tissue; Animals; Caffeine; Cyclic AMP; Epinephrine; | 1970 |
[Dietetics and nutrition in 1972].
Topics: Adipose Tissue; Alcoholic Intoxication; Anorexia Nervosa; Caffeine; Calcium; Catecholamines; Coffee; | 1972 |
[Studies on the gastric juice ratios in obesity].
Topics: Adult; Age Factors; Caffeine; Female; Gastric Acidity Determination; Gastric Juice; Gastric Mucosa; | 1971 |
Studies in spiny mice (Acomys cahirinus): metabolic state and pancreatic insulin release in vitro.
Topics: Age Factors; Animals; Antigens; Arginine; Blood Glucose; Caffeine; Calcium; Diabetes Mellitus; Gluca | 1969 |
[Study of the digestive function of the obese patients in total fasting].
Topics: Alkaline Phosphatase; Amino Acids; Biopsy; Caffeine; Calcium; Fasting; Gastric Juice; Glycoside Hydr | 1969 |